BioMedLib Search Engine [ goto HOMEPAGE ]

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer.

AIM: To evaluate the feasibility, efficacy and safety of intraoperative radiofrequency ablation (RFA) combined with (125)iodine seed implantation for unresectable pancreatic cancer.

METHODS: Thirty-two patients (21 males and 11 females) at the age of 68 years (range 48-90 years) with unresectable locally advanced pancreatic cancer admitted to our hospital from January 2006 to May 2008 were enrolled in this study.

The tumor, 4-12 cm in diameter, located in pancreatic head of 23 patients and in pancreatic body and tail of 9 patients, was found to be unresectable during operation.

Diagnosis of pancreatic cancer was made through intraoperative biopsy.

CONCLUSION: Intraoperative RFA combined with (125)iodine seed implantation is a feasible and safe procedure for unresectable pancreatic cancer with acceptable minor complications, and can prolong the survival time of patients, especially those at stage III.

[MeSH-major] Adenocarcinoma / therapy. Catheter Ablation / methods. Iodine Radioisotopes / therapeutic use. Pancreatic Neoplasms / therapy. Radiotherapy / methods

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

MedlinePlus Health Information. consumer health - Radiation Therapy.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Cancer. 2003 Feb 1;97(3):554-60 [12548596.001]

[Cites] Breast Cancer. 2003;10(1):4-9 [12525756.001]

[Cites] Cancer. 2003 Mar 1;97(5):1346-52 [12599244.001]

[Cites] Eur J Surg Oncol. 2004 Feb;30(1):85-7 [14736529.001]

[Cites] N Engl J Med. 2004 Mar 18;350(12):1200-10 [15028824.001]

[Cites] Pancreas. 2004 Apr;28(3):219-30 [15084961.001]

[Cites] Lancet. 1974 Nov 9;2(7889):1127-31 [4139420.001]

[Cites] Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):931-5 [2808054.001]

[Cites] Ann Surg. 1990 Aug;212(2):132-9 [1695834.001]

[Cites] Int J Radiat Oncol Biol Phys. 1992;23(2):305-11 [1587751.001]

[Cites] Lifetime Data Anal. 1999;5(1):81-90 [10214004.001]

[Cites] Gastrointest Endosc. 1999 Sep;50(3):392-401 [10462663.001]

[Cites] Minim Invasive Neurosurg. 2004 Dec;47(6):325-8 [15674746.001]

[Cites] Clin Liver Dis. 2005 May;9(2):301-14, viii [15831275.001]

[Cites] Hepatogastroenterology. 2005 Jul-Aug;52(64):1281-92 [16001679.001]

[Cites] Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1345-50 [16029791.001]

[Cites] Expert Rev Anticancer Ther. 2005 Aug;5(4):657-66 [16111466.001]

[Cites] Invest Radiol. 2005 Sep;40(9):583-90 [16118551.001]

[Cites] Prostate. 2005 Nov 1;65(3):260-7 [16015591.001]

[Cites] Eur J Radiol. 2005 Dec;56(3):403-8 [15964164.001]

[Cites] JOP. 2006;7(1):1-4 [16407612.001]

[Cites] JOP. 2006;7(1):74-8 [16407624.001]

[Cites] J Surg Oncol. 2006 May 1;93(6):485-90 [16615151.001]

[Cites] Langenbecks Arch Surg. 2007 Jan;392(1):55-60 [17089173.001]

[Cites] J Clin Oncol. 2007 May 20;25(15):1960-6 [17452677.001]

[Cites] Semin Oncol. 2007 Aug;34(4):327-34 [17674961.001]

[Cites] Ann Oncol. 2008 Jul;19(7):1224-30 [18381371.001]

[Cites] J Clin Oncol. 2009 Nov 20;27(33):5513-8 [19858379.001]

[Cites] Pancreas. 2000 Jan;20(1):14-20 [10630378.001]

[Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]

[Cites] Arch Surg. 2000 Mar;135(3):332-5 [10722037.001]

[Cites] Acta Chir Iugosl. 2002;49(3):19-24 [12587443.001]

(PMID = 20976848.001).

[ISSN] 2219-2840

[Journal-full-title] World journal of gastroenterology

[ISO-abbreviation] World J. Gastroenterol.

[Language] eng

[Publication-type] Evaluation Studies; Journal Article

[Publication-country] China

[Chemical-registry-number] 0 / Iodine Radioisotopes

[Other-IDs] NLM/ PMC2965288

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Treatment of pancreatic cancer--surgical point of view].

Although surgical techniques for pancreatic cancer have developed in a high level, the treatment results have not been improved and the 5 year survival rates after curative operation has been about 15% in Japan.

Retrospective studies on extended lymphadenectomy for ductal adenocarcinoma of the head of the pancreas revealed that extended surgery prolonged the survival for resected patients.

Finally, the clinical advantages of extended lymphadenectomy for pancreatic cancer was denied by several RCTs from Italy and U.S.A.

Further development of multidisciplinary treatments for pancreatic cancer is expected.

[MeSH-major] Carcinoma, Pancreatic Ductal / surgery. Lymph Node Excision / methods. Pancreatectomy. Pancreatic Neoplasms / surgery

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17637533.001).

[ISSN] 0385-0684

[Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy

[ISO-abbreviation] Gan To Kagaku Ryoho

[Language] jpn

[Publication-type] English Abstract; Journal Article; Review

[Publication-country] Japan

[Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine

[Number-of-references] 24

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Diagnostic features and differential diagnosis of autoimmune pancreatitis.

In about 15% to 20% of patients, the clinical stigmata of autoimmune conditions are present at the time of diagnosis, and in many others, discovered subsequently.

Most patients present with a pancreatic head mass, often with an accompanying stricture of the distal common bile duct, which thus radiologically resembles "pancreas cancer."

Elevated serum IgG4 levels are characteristic and may be very helpful in the differential diagnosis from tumors and tumor-like lesions of the pancreas which seldom result in levels above 135 mg/dL.

[MeSH-major] Autoimmune Diseases / diagnosis. Pancreatitis / diagnosis

[MeSH-minor] Adenocarcinoma / pathology. Adrenal Cortex Hormones / therapeutic use. Adult. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Humans. Male. Middle Aged

Genetic Alliance. consumer health - Pancreatitis.

MedlinePlus Health Information. consumer health - Autoimmune Diseases.

MedlinePlus Health Information. consumer health - Pancreatitis.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16939059.001).

[ISSN] 0740-2570

[Journal-full-title] Seminars in diagnostic pathology

[ISO-abbreviation] Semin Diagn Pathol

[Language] eng

[Publication-type] Journal Article; Review

[Publication-country] United States

[Chemical-registry-number] 0 / Adrenal Cortex Hormones

[Number-of-references] 91

   

Advertisement

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Rectal cancer metastasis to the head of the pancreas treated with pancreaticoduodenectomy.

We report a case of a 50-year-old man who developed metastatic pancreatic cancer from a primary rectal cancer that had been curatively removed 3 years previously.

The patient presented with a tumor that occupied the head of the pancreas, associated with obstructive jaundice, but the main pancreatic duct was not dilated.

The patient was initially diagnosed as having primary pancreatic cancer.

Cytological examination of the bile was conclusive for the presence of adenocarcinoma.

For 1 year, local disease progression was slow and no distant metastases developed; therefore, the initial diagnosis of pancreatic cancer was questioned.

On histology, including immunohistochemical staining for cytokeratin 20 (positive) and cytokeratin 7 (negative), the tumor was shown to be a metastatic pancreatic carcinoma that had originated from the original rectal cancer.

[MeSH-major] Pancreatic Neoplasms / secondary. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy. Rectal Neoplasms / pathology

[MeSH-minor] Angiography. Cholangiopancreatography, Magnetic Resonance. Diagnosis, Differential. Fatal Outcome. Humans. Immunohistochemistry. Male. Middle Aged

Genetic Alliance. consumer health - Rectal Cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18040627.001).

[ISSN] 0944-1166

[Journal-full-title] Journal of hepato-biliary-pancreatic surgery

[ISO-abbreviation] J Hepatobiliary Pancreat Surg

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Japan

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] A patient with nonfunctional pancreatic neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: case report.

Pancreatic neuroendocrine tumors constitute about 2% of all gastrointestinal neoplasms.

Approximately half of the pancreatic euroendocrine tumors are nonfunctional.

Due to lack of specific symptoms, most patients with nonfunctional pancreatic neuroendocrine tumors present with locally advanced or metastatic disease.

Colon carcinoma ranks third in frequency among primary sites of cancer in both men and women in western countries.

Presence of a metachronous colon adenocarcinoma in a patient with nonfunctional pancreatic neuroendocrine tumor has not been reported before.

We present a patient who had an asymptomatic mass in the head of the pancreas, detected by ultrasonography in 1996.

In 2002, after the diagnosis of an unresectable, nonfunctional pancreatic neuroendocrine tumor, interferon alpha- 2b and octreotide were started.

[MeSH-major] Adenocarcinoma / radionuclide imaging. Colonic Neoplasms / radionuclide imaging. Neoplasms, Second Primary / radionuclide imaging. Neuroendocrine Tumors / radionuclide imaging. Pancreatic Neoplasms / radionuclide imaging. Positron-Emission Tomography

Genetic Alliance. consumer health - Pancreatic islet cell tumors.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19821205.001).

[ISSN] 2148-5607

[Journal-full-title] The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

[ISO-abbreviation] Turk J Gastroenterol

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Turkey

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].

Complete resection (R0) remains the only potentially curative treatment of ductal adenocarcinoma of the pancreas.

[MeSH-major] Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Pancreatic Ductal / surgery. Pancreatic Neoplasms / pathology. Pancreatic Neoplasms / surgery

[MeSH-minor] Humans. Neoadjuvant Therapy. Neoplasm Recurrence, Local. Neoplasm, Residual. Pancreas / pathology. Pancreas / surgery. Pancreatectomy. Prognosis

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19091653.001).

[ISSN] 1769-6917

[Journal-full-title] Bulletin du cancer

[ISO-abbreviation] Bull Cancer

[Language] fre

[Publication-type] English Abstract; Journal Article; Review

[Publication-country] France

[Number-of-references] 29

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Inferior branch-preserving superior head resection of the pancreas with gastric wall-covering method for intraductal papillary mucinous adenoma.

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas showed significantly less aggressive pathologic features compared with common pancreatic cancer.

Therefore, several organ-preserving techniques, including duodenum-preserving pancreatic head resection, have been advocated in surgical procedures for IPMN.

We describe a surgical technique of superior head resection of the pancreas with inferior branch preservation followed by a gastric wall-covering method for the prevention of pancreatic leakage in patients with IPMN of the pancreas head.

[MeSH-major] Adenocarcinoma, Mucinous / surgery. Carcinoma, Pancreatic Ductal / surgery. Pancreatectomy / methods. Pancreatic Neoplasms / surgery. Stomach / surgery

[MeSH-minor] Abdominal Pain / diagnosis. Abdominal Pain / etiology. Aged. Anastomosis, Surgical. Cholangiopancreatography, Endoscopic Retrograde / methods. Follow-Up Studies. Humans. Immunohistochemistry. Male. Neoplasm Staging. Risk Assessment. Treatment Outcome

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16720158.001).

[ISSN] 0002-9610

[Journal-full-title] American journal of surgery

[ISO-abbreviation] Am. J. Surg.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Small pancreatic cancer with pancreas divisum preoperatively diagnosed by pancreatic juice cytology.

We present a case of small pancreatic head cancer with pancreas divisum preoperatively diagnosed by pancreatic juice cytology.

A 60-year-old woman was referred to our hospital for evaluation of a dilated main pancreatic duct (MPD).

A small and poorly reproducible low-echoic lesion in the pancreas was suspected by ultrasonography (US) and endoscopic ultrasonography (EUS).

Magnetic resonance cholangiopancreatography (MRCP) failed to visualize the ventral pancreatic duct, and the upstream dorsal pancreatic duct was dilated.

Endoscopic retrograde cholangiopancreatography (ERCP) was indicative of pancreas divisum, and complete obstruction of the MPD in the pancreatic head was seen.

Cytology of pancreatic juice obtained from the dorsal pancreas after minor papilla sphincterotomy revealed the presence of adenocarcinoma cells.

Pancreatoduodenectomy was performed under the diagnosis of pancreatic head cancer with pancreas divisum.

Histological examination revealed moderately-differentiated tubular adenocarcinoma 20 mm in diameter, located in the pancreatic head.

Dilatation of the dorsal pancreatic duct is sometimes observed in cases with pancreas divisum without the presence of tumors.

When pancreatic duct stenosis also exists in such cases, even if a tumor is not clearly visualized by diagnostic imaging, vigorous examinations such as pancreatic juice cytology are recommended to establish an accurate diagnosis.

[MeSH-major] Pancreas / abnormalities. Pancreatic Neoplasms / diagnosis

[MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Adenocarcinoma / ultrasonography. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Middle Aged. Pancreatic Juice / cytology

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19755770.001).

[ISSN] 1349-7235

[Journal-full-title] Internal medicine (Tokyo, Japan)

[ISO-abbreviation] Intern. Med.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Japan

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Advantage of pancreaticogastrostomy in detecting recurrent intraductal papillary mucinous carcinoma in the remnant pancreas: a case of successful re-resection after pancreaticoduodenectomy.

Recently there has been an increase in the number of case reports detailing the recurrence of cancer in the pancreatic remnants following surgical resection of intraductal papillary mucinous carcinoma (IPMC) of the pancreas.

A 68-year-old man underwent PD for IPMC of the pancreatic head, and the cut margin of the pancreatic duct was diagnosed as having no cancer but moderately dysplastic epithelium by an intraoperative frozen section of histology.

Eight years and 6 months later, during a routine follow-up examination, duct dilation of the remnant pancreas was detected by magnetic resonance imaging (MRI).

Upon examination by endoscopic gastroscopy, the anastomotic site was found to be covered with a large amount of mucin from which we easily obtained both cytologic and biopsied specimens, which subsequently proved positive for cancer.

In line with our diagnosis of recurrent IPMC, the patient underwent a second surgery (resection of the remnant pancreas, total pancreatectomy) and postoperative histology confirmed that indeed the patient had experienced recurrent IPMC with no nodal involvement or invasion beyond the pancreatic confines.

Based on this experience, we decided to recommend PG for all patients deemed to be at high risk for the recurrence of cancer in the pancreatic remnants following PD for IPMC of the pancreatic head.

[MeSH-major] Carcinoma, Pancreatic Ductal / surgery. Gastrostomy. Neoplasm Recurrence, Local / surgery. Pancreatic Ducts / surgery. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy

[MeSH-minor] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / surgery. Aged. Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / surgery. Follow-Up Studies. Gastroscopy. Humans. Magnetic Resonance Imaging. Male. Pancreatectomy. Reoperation

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Copyright 2006 Wiley-Liss, Inc.

(PMID = 16615155.001).

[ISSN] 0022-4790

[Journal-full-title] Journal of surgical oncology

[ISO-abbreviation] J Surg Oncol

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] An MRI-driven practice: a new perspective on MRI for the evaluation of adenocarcinoma of the head of the pancreas.

OBJECTIVES: The purpose of the study was to describe the MRI-driven management of masses at the head of the pancreas.

RESULTS: Between 2004 and 2008, we have treated 124 patients for a radiographic diagnosis of adenocarcinoma of the head of the pancreas.

This diagnosis was correct in 96.0% of the time.

CONCLUSION: MRI is a useful tool in the preoperative imaging of pancreatic head lesions that is highly sensitive and very specific for resectable disease.

[MeSH-major] Adenocarcinoma / diagnosis. Magnetic Resonance Imaging / methods. Pancreatic Neoplasms / diagnosis

[MeSH-minor] Aged. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Pancreaticoduodenectomy. Prognosis. Reproducibility of Results. Retrospective Studies. Sensitivity and Specificity. Time Factors

MedlinePlus Health Information. consumer health - MRI Scans.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] AJR Am J Roentgenol. 2002 Sep;179(3):717-24 [12185052.001]

[Cites] Br J Surg. 2001 Mar;88(3):325-37 [11260096.001]

[Cites] J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45 [16012297.001]

[Cites] Abdom Imaging. 2005 Jul-Aug;30(4):488-500 [15759205.001]

[Cites] N Engl J Med. 1992 Feb 13;326(7):455-65 [1732772.001]

[Cites] J Am Coll Surg. 2008 Mar;206(3):445-50 [18308214.001]

[Cites] J Gastrointest Surg. 1999 Sep-Oct;3(5):506-11 [10482707.001]

[Cites] Clin Gastroenterol Hepatol. 2008 Dec;6(12 ):1301-8 [18948228.001]

[Cites] Ann Surg Oncol. 2006 Aug;13(8):1035-46 [16865597.001]

[Cites] Ann Surg. 1996 Feb;223(2):134-40 [8597506.001]

[Cites] Am J Surg. 2006 Dec;192(6):888-93 [17161114.001]

[Cites] J Gastrointest Surg. 2004 Mar-Apr;8(3):280-8 [15019924.001]

[Cites] J Am Coll Surg. 2008 May;206(5):833-46; discussion 846-8 [18471707.001]

[Cites] Radiology. 1995 May;195(2):327-32 [7724748.001]

[Cites] Arch Surg. 2000 Apr;135(4):409-14; discussion 414-5 [10768705.001]

[Cites] Radiology. 2002 Jul;224(1):34-41 [12091659.001]

(PMID = 20467829.001).

[ISSN] 1873-4626

[Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

[ISO-abbreviation] J. Gastrointest. Surg.

[Language] eng

[Publication-type] Comparative Study; Journal Article

[Publication-country] United States

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma.

The most common sites of extrahepatic carcinoma are the stomach and ovary, but nine cases of hepatocellular differentiation of the pancreas have been reported in the literature.

We report another case of hepatoid carcinoma of the pancreas that was associated with the development of a pancreatic endocrine carcinoma in a 46-year-old man.

Serum alpha-fetoprotein (AFP) was elevated to 262.49 IU/mL and radiological examinations revealed a mass measuring 7.5 cm in diameter in the head of the pancreas.

He underwent a conventional Whipple operation, and light microscopy showed adenocarcinoma that was immunopositive for AFP, hepatocyte antigen, cytokeratin, chromogranin, synaptophysin, and alpha-1 antichymotrypsin.

Although hepatoid differentiation was not shown unequivocally histologically, other immunohistochemistry findings supported the diagnosis of hepatoid carcinoma combined with neuroendocrine carcinoma.

This report describes why hepatoid carcinoma should be considered as a differential diagnosis of a pancreatic mass, especially when serum AFP is elevated.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Am J Surg Pathol. 2007 Jan;31(1):146-52 [17197931.001]

[Cites] Cancer. 2000 Apr 1;88(7):1582-9 [10738216.001]

[Cites] Am Surg. 2004 Nov;70(11):1030-3 [15586521.001]

[Cites] Am J Gastroenterol. 1999 Jun;94(6):1658-63 [10364040.001]

[Cites] Mayo Clin Proc. 1997 Dec;72(12):1154-60 [9413299.001]

[Cites] Cancer. 1993 Sep 15;72(6):1827-35 [7689918.001]

[Cites] Cancer. 1993 Jan 15;71(2):293-6 [7678544.001]

[Cites] Hepatogastroenterology. 1992 Jun;39(3):282-6 [1380476.001]

[Cites] Cancer. 1986 Jul 1;58(1):119-26 [2423220.001]

[Cites] Cancer. 1985 Aug 15;56(4):840-8 [2410093.001]

[Cites] Cell Differ. 1986 Mar;18(2):109-17 [3513967.001]

[Cites] Am J Clin Pathol. 1987 Nov;88(5):639-45 [3673946.001]

[Cites] Lab Invest. 1990 May;62(5):552-61 [2342330.001]

[Cites] Ann N Y Acad Sci. 1983;417:105-7 [6200025.001]

[Cites] Proc Natl Acad Sci U S A. 1981 Apr;78(4):2577-81 [6941311.001]

[Cites] Cancer Res. 1972 May;32(5):979-82 [4111729.001]

[Cites] J Gastroenterol. 2006 Oct;41(10):1011-9 [17096071.001]

(PMID = 20479919.001).

[ISSN] 2005-1212

[Journal-full-title] Gut and liver

[ISO-abbreviation] Gut Liver

[Language] eng

[Publication-type] Journal Article

[Publication-country] Korea (South)

[Other-IDs] NLM/ PMC2871600

[Keywords] NOTNLM ; Hepatoid carcinoma / Neuroendocrine carcinoma / Pancreas

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas.

The aim of the present study was to examine the relationship between the clinicopathological status, the pre- and postoperative systemic inflammatory response and survival in patients undergoing potentially curative resection for ductal adenocarcinoma of the head of the pancreas.

Patients (n = 65) who underwent resection of ductal adenocarcinoma of the head of pancreas between 1993 and 2001, and had pre- and postoperative measurements of C-reactive protein, were included in the study.

The majority of patients had stage III disease (International Union Against Cancer Criteria, IUCC), positive circumferential margin involvement (R1), tumour size greater than 25 mm with perineural and lymph node invasion and died within the follow-up period.

The results of the present study indicate that, in patients who have undergone potentially curative resection for ductal adenocarcinoma of the head of pancreas, the presence of a systemic inflammatory response predicts poor outcome.

[MeSH-major] Carcinoma, Pancreatic Ductal / immunology. Inflammation / complications. Pancreatic Neoplasms / immunology

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Nutr Cancer. 2000;37(1):36-40 [10965517.001]

[Cites] Surg Today. 1999;29(1):16-22 [9934826.001]

[Cites] Lancet. 2001 Feb 17;357(9255):539-45 [11229684.001]

[Cites] Curr Oncol Rep. 2002 May;4(3):250-5 [11937016.001]

[Cites] Nature. 2002 Dec 19-26;420(6917):860-7 [12490959.001]

[Cites] Br J Surg. 2003 Feb;90(2):215-9 [12555298.001]

[Cites] Eur J Surg Oncol. 2003 May;29(4):368-73 [12711291.001]

[Cites] Ann Surg. 2003 Aug;238(2):197-202 [12894012.001]

[Cites] Br J Cancer. 2004 May 4;90(9):1707-9 [15150596.001]

[Cites] Anticancer Res. 1994 Mar-Apr;14(2B):657-66 [8010724.001]

[Cites] Cancer. 1995 Apr 15;75(8):2077-82 [7535184.001]

[Cites] Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3 [7794076.001]

[Cites] CA Cancer J Clin. 1996 Jan-Feb;46(1):5-27 [8548526.001]

[Cites] Ann Surg. 1996 Feb;223(2):147-53 [8597508.001]

[Cites] Langenbecks Arch Surg. 1998 Apr;383(2):116-20 [9641883.001]

[Cites] Oncology. 2000 Nov;59(4):296-301 [11096341.001]

(PMID = 15597096.001).

[ISSN] 0007-0920

[Journal-full-title] British journal of cancer

[ISO-abbreviation] Br. J. Cancer

[Language] eng

[Publication-type] Journal Article

[Publication-country] England

[Chemical-registry-number] 9007-41-4 / C-Reactive Protein

[Other-IDs] NLM/ PMC2361749

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Cerebellar metastasis from pancreatic adenocarcinoma. A case report.

The first discovery of a cerebellar metastasis of pancreatic carcinoma in a living patient is described.

Two years earlier the patient had undergone a pancreaticoduodenectomy for an adenocarcinoma of the head of the pancreas with a lymph node metastasis.

Clinical evaluation revealed an intracranial tumor without signs of pancreatic recurrence.

[MeSH-major] Adenocarcinoma / secondary. Cerebellar Neoplasms / radiography. Cerebellar Neoplasms / secondary. Pancreatic Neoplasms / pathology

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Copyright (c) 2006 S. Karger AG, Basel and IAP.

(PMID = 16636605.001).

[ISSN] 1424-3903

[Journal-full-title] Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

[ISO-abbreviation] Pancreatology

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Switzerland

[Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.

Thus, a variety of types of partial pancreatic resections have been advocated for treating these low-grade malignant tumors.

METHODS: We performed a retrospective review of the clinicopathologic features and surgical outcome in 15 patients who underwent inferior head resection for IPMN at the Chiba University Hospital and National Cancer Center Hospital East between July 1994 and January 2007.

Subsequent pancreatoduodenectomy was performed in one patient because of noninvasive carcinoma with multiple mucous lakes in the pancreatic parenchyma.

Pancreatic fistula occurred in 7 (47%) patients.

Two patients died of pancreatic ductal adenocarcinoma, 30 and 78 months after inferior head resection.

CONCLUSIONS: Pancreatic endocrine and exocrine function was well preserved after inferior head resection.

Pancreatic fistula occurred more frequently after inferior head resection than with conventional pancreatoduodenectomy.

[MeSH-major] Adenocarcinoma, Mucinous / surgery. Carcinoma, Pancreatic Ductal / surgery. Carcinoma, Papillary / surgery. Pancreatectomy / methods. Pancreatic Neoplasms / surgery

[MeSH-minor] Biopsy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Retrospective Studies. Treatment Outcome

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19727540.001).

[ISSN] 1868-6982

[Journal-full-title] Journal of hepato-biliary-pancreatic sciences

[ISO-abbreviation] J Hepatobiliary Pancreat Sci

[Language] eng

[Publication-type] Comparative Study; Journal Article; Multicenter Study

[Publication-country] Japan

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.

Solid-pseudopapillary neoplasm (SPN) of the pancreas is a rare neoplasm reported to have a favourable prognosis because of its slow-growing behaviour.

Its clear cell variant creates challenges in distinction from other clear cell tumours in the pancreas.

Exploratory laparotomy revealed a 5.2 cm well-demarcated tumour in the head of the pancreas, which was treated with Whipple procedure.

Difficulties are recognized in differentiating clear-cell SPN from "sugar" tumours, metastatic renal cell carcinoma, clear-cell variant of pancreatic endocrine neoplasm and ductal adenocarcinoma.

When facing such difficulties, nuclear and cytoplamic beta-catenin, nuclear E-cadherin expressions and absence of membranous E-cadherin staining are useful in differentiating clear-cell SPN from other clear cell tumours in the pancreas.

[MeSH-major] Carcinoma, Papillary / pathology. Pancreatic Neoplasms / pathology

[MeSH-minor] Adult. Biomarkers, Tumor / analysis. Carcinoma, Islet Cell / diagnosis. Carcinoma, Pancreatic Ductal / diagnosis. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / secondary. Cell Nucleus / chemistry. Cell Nucleus / pathology. Cytoplasm / chemistry. Cytoplasm / pathology. Diagnosis, Differential. Female. Humans. Perivascular Epithelioid Cell Neoplasms / diagnosis

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 20514858.001).

[ISSN] 0126-8635

[Journal-full-title] The Malaysian journal of pathology

[ISO-abbreviation] Malays J Pathol

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Malaysia

[Chemical-registry-number] 0 / Biomarkers, Tumor

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Intraductal papillary mucinous neoplasms of the pancreas].

INTRODUCTION: Mucin-producing pancreatic tumors account for 1% of all malignant tumors of the pancreas.

Notable among these are intraductal papillary mucinous neoplasms of the pancreas, due to their variable clinical behavior, increased frequency, and the controversy surrounding the most suitable treatment and diagnostic methods.

PATIENTS AND METHOD: We performed a prospective review of patients with a diagnosis of intraductal papillary mucinous neoplasm of the pancreas between 1996 and 2001.

The most frequent localization was the pancreatic head.

Seven patients underwent pancreatic resection and only one patient was not surgically treated.

CONCLUSION: Intraductal papillary mucinous neoplasms of the pancreas generally appear in the sixth decade of life.

These neoplasms typically occur in the head of the pancreas.

[MeSH-major] Adenocarcinoma, Mucinous. Carcinoma, Papillary. Pancreatic Neoplasms

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16420930.001).

[ISSN] 0009-739X

[Journal-full-title] Cirugía española

[ISO-abbreviation] Cir Esp

[Language] spa

[Publication-type] English Abstract; Journal Article

[Publication-country] Spain

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Previously, we used the reverse transcription-polymerase chain reaction (RT-PCR) to show that mammaglobin (MGB1) can serve as a differential marker of breast cancer metastasis from primary lung cancer.

Of the other cancers examined, including 29 of the head and neck, eight of the thyroid, 106 of the lung, 35 of the gastrointestinal tract, three of the pancreas, 14 of the uterine cervix and 13 of the ovary, none were positive for MGB1 except a proportion of salivary gland tumors (6/11, 55%) and endometrial cancers (3/23, 13%).

In terms of practical diagnosis, MGB1 immunohistochemistry can serve as a differential marker of breast cancer metastasis from primary lung cancer for two reasons.

Firstly, HER2-positive breast cancer frequently lacks estrogen receptor expression, but MGB1 is expressed in about half of this subtype.

[MeSH-major] Adenocarcinoma / metabolism. Breast Neoplasms / metabolism. Neoplasm Proteins / metabolism. Uteroglobin / metabolism

[MeSH-minor] Biomarkers, Tumor / metabolism. Cell Count. Diagnosis, Differential. Disease-Free Survival. Female. Humans. Immunoenzyme Techniques. Japan / epidemiology. Lung Neoplasms / diagnosis. Lung Neoplasms / metabolism. Lung Neoplasms / secondary. Mammaglobin A. Neoplasm Staging. Receptors, Estrogen / metabolism. Survival Rate. Tissue Array Analysis

MedlinePlus Health Information. consumer health - Breast Cancer.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 17192791.001).

[ISSN] 0893-3952

[Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

[ISO-abbreviation] Mod. Pathol.

[Language] eng

[Publication-type] Journal Article; Research Support, Non-U.S. Gov't

[Publication-country] United States

[Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Mammaglobin A; 0 / Neoplasm Proteins; 0 / Receptors, Estrogen; 0 / SCGB2A2 protein, human; 9060-09-7 / Uteroglobin

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Pancreaticoduodenectomy remains the only potentially curative treatment for adenocarcinoma of the pancreas.

The aim of this study was to analyze prognostic factors impacting survival after R0 pancreaticoduodenectomy for adenocarcinoma in the head of the pancreas.

Between 1995 and 2002, a potentially curative (R0) pancreaticoduodenectomy with pancreatogastrostomy for ductal adenocarcinoma in the head of the pancreas was performed in 81 patients (42 women and 39 men) with a mean age of 64 years (range 35-84).

The main risk factor associated with poor survival after an R0 pancreaticoduodenectomy for adenocarcinoma in the head of pancreas was lymph node status: The presence of two or more positive lymph nodes was associated with decreased survival.

[MeSH-major] Adenocarcinoma / surgery. Carcinoma, Pancreatic Ductal / surgery. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Am J Surg. 2001 Aug;182(2):120-9 [11574081.001]

[Cites] Ann Surg. 1998 Oct;228(4):508-17 [9790340.001]

[Cites] Surgery. 1995 Jan;117(1):50-5 [7809836.001]

[Cites] Ann Surg. 2002 Sep;236(3):355-66; discussion 366-8 [12192322.001]

[Cites] Arch Surg. 2007 Feb;142(2):172-9; discussion 180 [17309969.001]

[Cites] Br J Surg. 1993 Dec;80(12):1575-8 [7507785.001]

[Cites] Ann Surg. 2003 Jan;237(1):74-85 [12496533.001]

[Cites] World J Surg. 1999 Sep;23(9):926-9 [10449822.001]

[Cites] Ann Surg. 2002 Aug;236(2):137-48 [12170018.001]

[Cites] Hepatogastroenterology. 2002 Jan-Feb;49(43):258-62 [11941970.001]

[Cites] Br J Surg. 2005 Sep;92(9):1150-4 [16035134.001]

[Cites] Ann Surg. 1990 Apr;211(4):447-58 [2322039.001]

[Cites] Am J Surg. 2006 Jun;191(6):726-32; discussion 733-4 [16720139.001]

[Cites] Br J Surg. 1996 May;83(5):625-31 [8689203.001]

[Cites] J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79 [11307091.001]

[Cites] Eur J Cancer. 2004 Mar;40(4):549-58 [14962722.001]

[Cites] Dig Surg. 2004;21(3):202-9 [15218236.001]

[Cites] Am J Gastroenterol. 2001 Sep;96(9):2609-15 [11569683.001]

[Cites] Arch Surg. 2004 Mar;139(3):327-35 [15006893.001]

[Cites] Ann Surg. 1999 May;229(5):613-22; discussion 622-4 [10235519.001]

[Cites] Br J Surg. 2003 Sep;90(9):1131-6 [12945082.001]

[Cites] Arch Pathol Lab Med. 2002 Oct;126(10):1169-73 [12296752.001]

[Cites] Ann Surg. 1997 Sep;226(3):248-57; discussion 257-60 [9339931.001]

[Cites] J Gastrointest Surg. 2006 Jun;10(6):813-22 [16769537.001]

[Cites] Surgery. 1997 Sep;122(3):553-66 [9308613.001]

[Cites] World J Surg. 1995 May-Jun;19(3):410-4; discussion 414-5 [7638998.001]

[Cites] Hepatogastroenterology. 1998 May-Jun;45(21):855-66 [9684147.001]

[Cites] Pancreas. 2003 Apr;26(3):243-9 [12657950.001]

[Cites] Ann Surg. 1996 Jun;223(6):718-25; discussion 725-8 [8645045.001]

(PMID = 17458610.001).

[ISSN] 1091-255X

[Journal-full-title] Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

[ISO-abbreviation] J. Gastrointest. Surg.

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma.

BACKGROUND: Intraductal papillary-mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN) of the pancreas have similar clinicopathologic findings.

METHODS: Medical records for 77 patients with pancreatic cystic neoplasms with mucin secretion were reviewed.

RESULTS: IPMNs consisted of 32 adenomas, 12 borderline neoplasms, 13 adenocarcinomas in situ, and 13 invasive adenocarcinomas; MCNs included 6 adenomas and 1 invasive adenocarcinoma.

The location of the pancreatic mass differed, with 76% 0f IPMNs occurring in the head, while 86% of MCNs occurred in the body or tail.

Mass mean size was significantly smaller (28 mm vs 78 mm, P < .001), and mean diameter of the main pancreatic duct was larger (6.8 mm vs 3.1 mm, P < .001) in IPMN than in MCN.

Communication between the cyst and main pancreatic duct was more frequent in IPMNs (67/70) than in MCNs (1/7).

[MeSH-major] Adenocarcinoma / pathology. Adenocarcinoma, Mucinous / pathology. Adenoma / pathology. Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Papillary / pathology. Stromal Cells / pathology

[MeSH-minor] Adult. Aged. Diagnosis, Differential. Disease Progression. Female. Humans. Male. Middle Aged. Ovary / cytology. Prognosis. Retrospective Studies. Survival Rate

[Email] Email this result item

Email the results to the following email address:   [X] Close

[CommentIn] Surgery. 2007 Apr;141(4):545-6 [17383536.001]

(PMID = 16934608.001).

[ISSN] 0039-6060

[Journal-full-title] Surgery

[ISO-abbreviation] Surgery

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].

We report a case of pancreas head cancer with liver metastasis treated with uracil-tegafur (UFT) and gemcitabine combined chemotherapy.

The histopathological diagnosis was adenocarcinoma, so we inserted a self-expandable metallic stent (EMS) in this inoperable pancreas head cancer.

Renewed liver metastases did not appear, and the pancreas head tumor partially responded.

[MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Deoxycytidine / analogs & derivatives. Pancreatic Neoplasms / drug therapy. Pancreatic Neoplasms / pathology. Tegafur / therapeutic use. Uracil / therapeutic use

Genetic Alliance. consumer health - Pancreatic cancer.

Genetic Alliance. consumer health - Metastatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19223756.001).

[ISSN] 0385-0684

[Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy

[ISO-abbreviation] Gan To Kagaku Ryoho

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Japan

[Chemical-registry-number] 0W860991D6 / Deoxycytidine; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; B76N6SBZ8R / gemcitabine

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

OBJECTIVE: To determine long-term survival after pancreatoduodenectomy for pancreatic ductal adenocarcinoma and to identify clinical factors associated with long-term survival.

SUMMARY BACKGROUND DATA: The prognosis for long-term survival even after potentially curative resection for pancreatic adenocarcinoma is thought to be poor.

Clinical factors determining short-term survival after pancreatic resection are well studied, but prognostic factors predicting long-term survival with a potential for cure are poorly understood.

METHODS: A case-control study was conducted of 357 patients who underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma between 1981 and 2001.

Histologic specimens were reanalyzed to confirm diagnosis.

Five-year survival was no guarantee of cure because 16% of this subset died of pancreatic cancer up to 7.8 years after operation.

CONCLUSION: Pancreatoduodenectomy for adenocarcinoma in the head of pancreas can provide long-term survival in a subset of patients, particularly in the absence of lymph node metastasis.

[MeSH-major] Adenocarcinoma / mortality. Adenocarcinoma / surgery. Pancreatic Neoplasms / mortality. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

COS Scholar Universe. author profiles.

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18376190.001).

[ISSN] 0003-4932

[Journal-full-title] Annals of surgery

[ISO-abbreviation] Ann. Surg.

[Language] eng

[Publication-type] Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / Serum Albumin

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Pancreatic and extrapancreatic lesions in patients with intraductal papillary mucinous neoplasms of the pancreas: a single-centre experience.

RESULTS: Pancreatic IPMN was localised in the head in 43 patients (30.3%), in the body in 13 (9.2%), in the tail in ten (7.0%), in the head-body in 17 (12.0%), in the body-tail in 15 (10.6%) diffuse throughout the gland in 44 (31.0%).

Twenty patients (14.1%) had associated pancreatic or extrapancreatic diseases.

In evaluating the distribution of pancreatic or extrapancreatic diseases according to IPMN type, we found that this was not significantly different among types I, II and III (p=0.776).

CONCLUSIONS: The majority of pancreatic and extrapancreatic cancers occur before the diagnosis of IPMNs is made and is not related to the type of IPMN.

[MeSH-major] Adenocarcinoma, Mucinous / pathology. Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Papillary / pathology. Diagnostic Imaging. Neoplasms, Multiple Primary / pathology. Neoplasms, Second Primary / pathology. Pancreatic Neoplasms / pathology

MedlinePlus Health Information. consumer health - Diagnostic Imaging.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Abdom Imaging. 2007 May-Jun;32(3):374-80 [16967247.001]

[Cites] J Gastrointest Surg. 2007 Mar;11(3):338-44 [17458608.001]

[Cites] J Magn Reson Imaging. 2005 Mar;21(3):237-44 [15723374.001]

[Cites] Radiology. 2006 Feb;238(2):560-9 [16436817.001]

[Cites] Pancreatology. 2006;6(1-2):17-32 [16327281.001]

[Cites] N Engl J Med. 1993 May 20;328(20):1433-7 [8479461.001]

[Cites] Gastroenterology. 2007 Jul;133(1):72-9; quiz 309-10 [17631133.001]

[Cites] Abdom Imaging. 2006 May-Jun;31(3):320-5 [16333711.001]

[Cites] AJR Am J Roentgenol. 2000 Feb;174(2):441-7 [10658722.001]

[Cites] Hepatogastroenterology. 2007 Jul-Aug;54(77):1579-81 [17708304.001]

[Cites] Int J Cancer. 2009 Aug 1;125(3):666-73 [19382179.001]

[Cites] Surgery. 2006 Jun;139(6):749-54 [16782429.001]

[Cites] Hepatobiliary Pancreat Dis Int. 2008 Apr;7(2):192-5 [18397857.001]

[Cites] J Gastrointest Surg. 2008 Apr;12(4):645-50 [18097728.001]

[Cites] J Am Coll Surg. 2007 May;204(5):803-13; discussion 813-4 [17481488.001]

[Cites] J Gastroenterol. 2008;43(3):181-5 [18373159.001]

[Cites] Clin Gastroenterol Hepatol. 2006 Apr;4(4):460-8 [16616351.001]

[Cites] Radiology. 1986 Dec;161(3):697-700 [3786719.001]

[Cites] Radiographics. 2005 Nov-Dec;25(6):1451-68; discussion 1468-70 [16284127.001]

[Cites] Radiol Med. 2008 Apr;113(3):414-28 [18493777.001]

[Cites] World J Surg. 2008 Feb;32(2):271-8; discussion 279-80 [18027021.001]

[Cites] Ann Surg Oncol. 2005 Feb;12(2):124-32 [15827792.001]

[Cites] Ann Surg. 1998 Nov;228(5):685-91 [9833807.001]

[Cites] Korean J Radiol. 2003 Jul-Sep;4(3):157-62 [14530644.001]

[Cites] Radiographics. 2001 Mar-Apr;21(2):323-37; discussion 337-40 [11259696.001]

[Cites] Am J Surg. 2007 Sep;194(3):304-7 [17693271.001]

[Cites] Clin Radiol. 2006 Sep;61(9):776-83 [16905386.001]

[Cites] Am J Gastroenterol. 2008 Nov;103(11):2878-82 [18853975.001]

[Cites] J Gastrointest Surg. 2008 Jan;12(1):101-9 [17917784.001]

(PMID = 20082228.001).

[ISSN] 1826-6983

[Journal-full-title] La Radiologia medica

[ISO-abbreviation] Radiol Med

[Language] eng; ita

[Publication-type] Journal Article

[Publication-country] Italy

[Chemical-registry-number] 0 / Contrast Media

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Immuno-histopathological correlations in exocrine pancreatic cancer.

OBJECTIVE: Study of CA19-9 antigen from the immunological point of view, at the patients with pancreatic cancer, and his relation with the histopathological aspects.

MATERIAL AND METHOD: The determinations have been done at the time of the diagnosis and after the treatment of the patients with pancreatic cancer (25).

RESULTS: The values of the CA19-9 marker have been increased at the time of the diagnosis either in pancreatic cancer of the head and mid.

At the moment of the diagnosis the CA19-9 marker has higher values (150-400 U/ml) in cancer of the pancreatic body than in cancer of the head of the pancreas (40-200 U/ml).

Correlating the size of the tumor with the value of the CA19-9 marker in the case of pancreatic cancer we have been shown the highest serum values (300-400 U/ml) at patients whose tumor was 3 cm bigger.

The highest values of the CA 19-9 marker were found in cases of mid pancreas adenocarcinoma.

CONCLUSION: CA19-9 marker values higher than normal cause problems to digestive cancer (especially pancreatic).

The high values of CA 19-9 suggest an adenocarcinoma.

[MeSH-major] CA-19-9 Antigen / analysis. Pancreatic Neoplasms / immunology. Pancreatic Neoplasms / pathology

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16287000.001).

[ISSN] 1220-0522

[Journal-full-title] Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

[ISO-abbreviation] Rom J Morphol Embryol

[Language] eng

[Publication-type] Journal Article

[Publication-country] Romania

[Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Chronic pancreatitis as a risk factor for the development of pancreatic cancer--diagnostic challenges].

Patients with chronic pancreatitis are burdened with an increased risk of developing pancreatic cancer.

Strategies or guidelines for the surveillance and early detection of pancreatic adenocarcinoma in patients with chronic pancreatitis are not established, because available clinical, serologic or imaging techniques are still of limited sensitivity and specificity.

Despite these limitations do patients with chronic pancreatitis and suspected pancreatic cancer need a careful and sometimes repeated diagnostic work-up.

A clear benefit of surveillance programs outside of clinical trials for the early detection of pancreatic cancer has not been demonstrated.

A 51-year-old patient with chronic pancreatitis is reported who developed cancer of the pancreatic head while undergoing repeated imaging studies.

[MeSH-major] Carcinoma, Pancreatic Ductal / diagnosis. Pancreatic Neoplasms / diagnosis. Pancreatitis, Alcoholic / diagnosis

[MeSH-minor] Anastomosis, Roux-en-Y. Disease Progression. Early Diagnosis. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Pancreas / pathology. Pancreatectomy. Tomography, X-Ray Computed. Ultrasonography

Genetic Alliance. consumer health - Pancreatic cancer.

Genetic Alliance. consumer health - Pancreatitis.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Surgery. 1997 Jul;122(1):53-9 [9225915.001]

[Cites] Gastroenterology. 1952 May;21(1):54-63 [14926813.001]

[Cites] J Biol Chem. 2002 Feb 15;277(7):5404-10 [11719509.001]

[Cites] Am J Gastroenterol. 2009 Sep;104(9):2175-81 [19491823.001]

[Cites] Gut. 2009 Oct;58(10):1410-8 [19470496.001]

[Cites] Gut. 2007 Oct;56(10):1460-9 [17872573.001]

[Cites] Curr Gastroenterol Rep. 2004 Apr;6(2):104-10 [15191687.001]

[Cites] Chirurg. 2004 Jul;75(7):731-47; quiz 748 [15205751.001]

[Cites] Br J Surg. 1999 Feb;86(2):189-93 [10100785.001]

[Cites] Am J Gastroenterol. 2004 Jul;99(7):1258-66 [15233663.001]

[Cites] Clin Gastroenterol Hepatol. 2006 Aug;4(8):1010-6; quiz 934 [16843735.001]

[Cites] Int J Pancreatol. 2000 Apr;27(2):93-103 [10862508.001]

[Cites] N Engl J Med. 1993 May 20;328(20):1433-7 [8479461.001]

[Cites] JAMA. 2001 Jul 11;286(2):169-70 [11448279.001]

[Cites] Gastrointest Endosc. 2002 Jul;56(1):66-71 [12085037.001]

[Cites] Am J Gastroenterol. 2008 Jan;103(1):111-9 [18184119.001]

[Cites] Am J Gastroenterol. 1990 Oct;85(10):1427-8 [2220745.001]

[Cites] Int J Biochem Cell Biol. 2004 Aug;36(8):1386-92 [15147717.001]

[Cites] Clin Gastroenterol Hepatol. 2004 Mar;2(3):252-61 [15017610.001]

[Cites] Am J Gastroenterol. 2004 May;99(5):844-50 [15128348.001]

[Cites] Gastrointest Endosc. 1998 Jul;48(1):11-7 [9684658.001]

[Cites] Nat Clin Pract Gastroenterol Hepatol. 2007 Jun;4(6):314-23 [17541445.001]

[Cites] Nat Genet. 1996 Oct;14(2):141-5 [8841182.001]

[Cites] Lancet Oncol. 2009 Jan;10(1):88-95 [19111249.001]

[Cites] Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1295-9 [15618835.001]

[Cites] Pancreatology. 2001;1(5):405-15 [12120217.001]

[Cites] Pancreas. 2003 Nov;27(4):321-6 [14576495.001]

[Cites] Pancreas. 2009 Nov;38(8):846-8 [19855232.001]

[Cites] Med Clin North Am. 2000 May;84(3):531-47, vii [10872412.001]

[Cites] J Natl Cancer Inst. 1997 Mar 19;89(6):442-6 [9091646.001]

[Cites] J Natl Cancer Inst. 1994 Apr 20;86(8):625-7 [8145277.001]

[Cites] J Eval Clin Pract. 2009 Feb;15(1):62-8 [19239583.001]

[Cites] Clin Gastroenterol Hepatol. 2006 Jun;4(6):766-81; quiz 665 [16682259.001]

(PMID = 20455050.001).

[ISSN] 1615-6722

[Journal-full-title] Medizinische Klinik (Munich, Germany : 1983)

[ISO-abbreviation] Med. Klin. (Munich)

[Language] ger

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Germany

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Mangafodipir-DPDP enhanced MRI visualization of a pancreatic adenocarcinoma previously undetected by extracellular contrast enhanced CT and MRI.

We report a case of adenocarcinoma of the head of the pancreas, occult at extracellular contrast enhanced MDCT and magnetic resonance imaging (MRI), which was detected by MRI only with the use of a tissue-specific contrast agent (Mangafodipir trisodium Mn- DPDP).

The histological examination after duodenopancreatectomy confirmed the diagnosis.

Contrast-enhanced multi-detector computed tomography (MDCT) is currently considered to be the reference method for diagnosing and staging of pancreatic adenocarcinoma.

The technological evolution of magnetic resonance imaging and the development of organ-specific contrast media for liver and pancreas have led to a progressively more extensive use of this method for the investigation of suspected lesions.

[MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / radiography. Contrast Media. Edetic Acid / analogs & derivatives. Magnetic Resonance Imaging / methods. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / radiography. Pyridoxal Phosphate / analogs & derivatives. Tomography, X-Ray Computed

[MeSH-minor] Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Middle Aged. Pancreas / pathology. Pancreaticoduodenectomy

MedlinePlus Health Information. consumer health - CT Scans.

MedlinePlus Health Information. consumer health - MRI Scans.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

Hazardous Substances Data Bank. Disodium EDTA .

Hazardous Substances Data Bank. ETHYLENEDIAMINE TETRAACETIC ACID .

Hazardous Substances Data Bank. DISODIUM CALCIUM EDTA .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18330084.001).

[ISSN] 0392-4203

[Journal-full-title] Acta bio-medica : Atenei Parmensis

[ISO-abbreviation] Acta Biomed

[Language] eng

[Publication-type] Case Reports; Comparative Study; Journal Article

[Publication-country] Italy

[Chemical-registry-number] 0 / Contrast Media; 5V5IOJ8338 / Pyridoxal Phosphate; 9G34HU7RV0 / Edetic Acid; P28BIW0UTB / N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Mixed ductal-endocrine carcinoma of the pancreas with synchronous papillary carcinoma-in-situ of the common bile duct: a case report and literature review--synchronous pancreatic and bile duct tumors.

This report is a case of a 58-year-old woman with a mixed ductal-endocrine carcinoma of the pancreas and a synchronous carcinoma-in-situ of the common bile duct.

Biopsies from this lesion showed adenocarcinoma.

Subsequently, pancreatoduodenectomy was performed for the diagnosis of peri-ampullary carcinoma.

Gross examination revealed a 2-cm irregular, ulcerated lesion obstructing the distal 0.5 cm of the common bile duct within the head of the pancreas.

On histopathological examination, it was discovered that this lesion contained two separate neoplasms: papillary carcinoma-in-situ of the intraparenchymal portion of the common bile duct and a mixed ductal-endocrine carcinoma of the pancreas.

Mixed ductal-endocrine carcinoma of the pancreas is very rare.

[MeSH-major] Carcinoma in Situ / pathology. Carcinoma, Pancreatic Ductal / pathology. Common Bile Duct Neoplasms / pathology. Neoplasms, Multiple Primary / pathology. Pancreatic Neoplasms / pathology

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for mixed ductal-endocrine carcinoma .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18453301.001).

[ISSN] 0003-1348

[Journal-full-title] The American surgeon

[ISO-abbreviation] Am Surg

[Language] eng

[Publication-type] Case Reports; Journal Article; Review

[Publication-country] United States

[Number-of-references] 8

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].

OBJECTIVE: To study the clinicopathologic features and diagnosis of intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

It affected patients in older age group (mean age = 59) and was located mainly in the head of pancreas (60%).

Histologically, the tumor consisted of papillary proliferations protruding into and expanding the pancreatic ducts.

Invasion into the surrounding pancreatic parenchyma was noted in 12 cases and chronic pancreatitis was present in 16 cases.

The prognosis after surgical resection however is better than that of conventional pancreatic adenocarcinoma.

Early recognition by radiologic examination (including ERCP) and pancreatic cytology would be helpful in early diagnosis.

[MeSH-major] Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Papillary / pathology. Immunohistochemistry / trends. Pancreatic Neoplasms / pathology

[MeSH-minor] Adaptor Proteins, Signal Transducing / analysis. Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / metabolism. Adult. Aged. Cell Cycle Proteins / analysis. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Ki-67 Antigen / analysis. Male. Middle Aged. Pancreas / metabolism. Pancreas / pathology. Pancreatectomy. Pancreatic Ducts / metabolism. Pancreatic Ducts / pathology. Prognosis. Receptor, ErbB-2 / analysis. Treatment Outcome

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

The Lens. Cited by Patents in .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19094485.001).

[ISSN] 0529-5807

[Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology

[ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi

[Language] chi

[Publication-type] English Abstract; Journal Article

[Publication-country] China

[Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / CDCA5 protein, human; 0 / Cell Cycle Proteins; 0 / Ki-67 Antigen; EC 2.7.10.1 / Receptor, ErbB-2

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Synchronous double invasive ductal carcinomas of the pancreas with multifocal branch duct intraductal papillary mucinous neoplasms of the pancreas].

A 52-year-old man with a history of distal gastrectomy for gastric cancer was admitted to our hospital because of jaundice.

CT scan revealed double tumors in the pancreatic head and body concomitant with multicystic lesions of the pancreas.

Final histological diagnosis was double invasive ductal carcinomas of the pancreas head and tail with multifocal branch duct intraductal papillary mucinous adenomas of the pancreas.

The present case suggests that entire pancreas might have malignant potential in patients with intraductal papillary mucinous neoplasms.

[MeSH-major] Adenocarcinoma, Mucinous / surgery. Carcinoma, Pancreatic Ductal / surgery. Carcinoma, Papillary / surgery. Neoplasms, Multiple Primary. Pancreatic Neoplasms / surgery

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19122428.001).

[ISSN] 0446-6586

[Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology

[ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Japan

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Single-branch resection of the pancreas.

The treatment of intraductal papillary mucinous tumors (IPMT) of the pancreas is still controversial.

In this report we describe a single-branch resection of the pancreas (SBRP), which is a new method for the removal of branch-type IPMT of the head of the pancreas.

A multilobular cystic lesion (50 x 40 mm) in the head of the pancreas was incidentally detected in an asymptomatic 40-year-old man who underwent a routine ultrasound examination.

The tumor was carefully removed along the border of the cyst and the normal parenchyma, with complete preservation of the main pancreatic duct and the common bile duct.

A pancreatic fistula developed during the postoperative period, but was well-controlled by endoscopic naso-pancreatic drainage.

SBRP is a technically feasible procedure and this operation represents a minimally invasive alternative to any other segmental resection of the pancreas.

[MeSH-major] Adenocarcinoma, Mucinous / surgery. Adenocarcinoma, Papillary / surgery. Pancreatectomy / methods. Pancreatic Neoplasms / surgery

[MeSH-minor] Adult. Diagnosis, Differential. Diagnostic Imaging. Humans. Male

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15754104.001).

[ISSN] 0944-1166

[Journal-full-title] Journal of hepato-biliary-pancreatic surgery

[ISO-abbreviation] J Hepatobiliary Pancreat Surg

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Japan

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I(131) KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma.

BACKGROUND: Advanced pancreatic cancer has a poor prognosis, and the current standard of care (gemcitabine based chemotherapy) provides a small survival advantage.

This study aimed to evaluate the safety and tolerability of KAb201, an anti-carcinoembryonic antigen monoclonal antibody, labelled with I(131) in pancreatic cancer (ISRCTN 16857581).

METHODS: Patients with histological/cytological proven inoperable adenocarcinoma of the head of pancreas were randomised to receive KAb 201 via either the intra-arterial or intravenous delivery route.

[MeSH-major] Adenocarcinoma / diagnostic imaging. Carcinoembryonic Antigen / administration & dosage. Immunotoxins / administration & dosage. Iodine Radioisotopes / administration & dosage. Pancreatic Neoplasms / radiotherapy. Radioimmunotherapy / methods

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

COS Scholar Universe. author profiles.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Clin Cancer Res. 1999 Oct;5(10 Suppl):3232s-3242s [10541369.001]

[Cites] CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96 [18287387.001]

[Cites] Clin Cancer Res. 2000 Feb;6(2):406-14 [10690517.001]

[Cites] Teratog Carcinog Mutagen. 2001;21(1):45-57 [11135320.001]

[Cites] Cancer Res. 2001 Sep 15;61(18):6851-9 [11559561.001]

[Cites] Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66 [11602373.001]

[Cites] Cancer. 2002 Feb 15;94(4 Suppl):1373-81 [11877768.001]

[Cites] Cancer. 2002 Feb 15;94(4):902-10 [11920457.001]

[Cites] J Clin Oncol. 2002 Aug 1;20(15):3270-5 [12149301.001]

[Cites] Clin Colorectal Cancer. 2002 May;2(1):31-42 [12453334.001]

[Cites] Aliment Pharmacol Ther. 2003 Dec;18(11-12):1049-69 [14653825.001]

[Cites] Int J Cancer. 2004 Apr 20;109(4):618-26 [14991585.001]

[Cites] J Natl Cancer Inst. 1976 Jul;57(1):11-22 [794493.001]

[Cites] Ann N Y Acad Sci. 1983;417:75-85 [6200051.001]

[Cites] Cancer Metastasis Rev. 1987;6(4):559-93 [3327633.001]

[Cites] Cell. 1989 Apr 21;57(2):327-34 [2702691.001]

[Cites] J Surg Oncol. 1991 Jul;47(3):148-54 [2072697.001]

[Cites] J Nucl Med. 1997 Jun;38(6):858-70 [9189130.001]

[Cites] J Clin Oncol. 1997 Jun;15(6):2403-13 [9196156.001]

[Cites] J Nucl Med. 1998 Jan;39(1):34-42 [9443735.001]

[Cites] Hepatogastroenterology. 1998 Jul-Aug;45(22):1125-9 [9756018.001]

[Cites] Hybridoma. 1999 Apr;18(2):183-91 [10380018.001]

[Cites] Surgery. 2005 Jun;137(6):597-605 [15962401.001]

[Cites] Nat Biotechnol. 2005 Sep;23(9):1147-57 [16151408.001]

[Cites] Ann Nucl Med. 2005 Jul;19(5):355-65 [16164191.001]

[Cites] J Nucl Med. 2006 Feb;47(2):196-9 [16455623.001]

[Cites] J Nucl Med. 2006 Feb;47(2):247-55 [16455630.001]

[Cites] J Clin Oncol. 2006 Feb 10;24(5):823-34 [16380412.001]

[Cites] J Clin Oncol. 2006 Mar 20;24(9):1395-403 [16505413.001]

[Cites] J Clin Oncol. 2006 Aug 20;24(24):3946-52 [16921047.001]

[Cites] Q J Nucl Med Mol Imaging. 2006 Dec;50(4):248-64 [17043623.001]

[Cites] Curr Drug Discov Technol. 2006 Dec;3(4):231-43 [17430101.001]

[Cites] J Clin Oncol. 2007 May 20;25(15):1960-6 [17452677.001]

[Cites] J Clin Oncol. 2007 Jun 20;25(18):2607-15 [17577041.001]

[Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]

(PMID = 19243606.001).

[ISSN] 1471-2407

[Journal-full-title] BMC cancer

[ISO-abbreviation] BMC Cancer

[Language] eng

[Databank-accession-numbers] ISRCTN/ ISRCTN16857581

[Grant] United Kingdom / Medical Research Council / / G9900432; United Kingdom / Cancer Research UK / /

[Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

[Publication-country] England

[Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Neoplasm; 0 / Carcinoembryonic Antigen; 0 / Immunotoxins; 0 / Iodine Radioisotopes

[Other-IDs] NLM/ PMC2656541

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Local recurrence after surgical resection of pancreatic cancer effectively treated with combined chemoradiotherapy].

We report a patient for whom systemic chemotherapy using gemcitabine was effective against local recurrence of pancreatic cancer.

A 59-year-old man underwent pancreatoduodenectomy for pancreatic head cancer.

The diagnosis was moderately-differentiated tubular adenocarcinoma(tubular type, pT2, pN0, fM0, fStage II ).

Ten months after surgery, the patient had a CT examination which revealed a mass at the cut-end of the pancreas.

Twenty-one months after chemotherapy, CT examination revealed regrowth at the same location at the cut-end of the pancreas, and so radiotherapy was performed at a total 63 Gy.

[MeSH-major] Adenocarcinoma / therapy. Pancreatic Neoplasms / therapy

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19542722.001).

[ISSN] 0385-0684

[Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy

[ISO-abbreviation] Gan To Kagaku Ryoho

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Japan

[Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen; 0W860991D6 / Deoxycytidine; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; B76N6SBZ8R / gemcitabine; 1-UFT protocol

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Multifocal pancreatic intraepithelial neoplasia (PanIN) lesions of the branch ducts associated with lobular parenchymal atrophy in a Japanese patient diagnosed to have familial pancreatic cancer.

This report presents a case of Japanese familial pancreatic cancer (FPC) with multifocal pancreatic intraepithelial neoplasia (PanIN) lesions of the branch ducts probably associated with lobular parenchymal atrophy.

The risk of pancreatic cancer is significantly increased in those associated with FPC, and this risk increases with increasing numbers of affected first-degree relatives, but there have been four Japanese cases reported.

A 63-year-old Japanese male was referred to the hospital for evaluation and treatment of a pancreatic head tumor.

His family history included pancreatic cancer in two-first-degree relatives and three-second-degree relatives.

The histological findings of the main tumor showed a moderately differentiated tubular adenocarcinoma in the head of the pancreas without metastasis of the resected lymph nodes.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Pancreatology. 2007;7(4):341-6 [17703080.001]

[Cites] Am J Surg Pathol. 2004 Aug;28(8):977-87 [15252303.001]

[Cites] Gut. 2007 Oct;56(10):1460-9 [17872573.001]

[Cites] Nat Genet. 2000 Jun;25(2):213-6 [10835640.001]

[Cites] Curr Treat Options Oncol. 2005 Sep;6(5):437-45 [16107246.001]

[Cites] Cancer Res. 2002 Jul 1;62(13):3789-93 [12097290.001]

[Cites] Cancer Res. 1996 Dec 1;56(23):5360-4 [8968085.001]

[Cites] Am J Pathol. 1999 Jun;154(6):1835-40 [10362809.001]

[Cites] Am J Surg Pathol. 2001 May;25(5):579-86 [11342768.001]

[Cites] Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):253-83 [16549327.001]

[Cites] Am J Surg Pathol. 2006 Sep;30(9):1067-76 [16931950.001]

[Cites] Ann Surg. 2002 Dec;236(6):730-7 [12454511.001]

[Cites] Gan No Rinsho. 1984 Aug;30(10):1331-6 [6481970.001]

[Cites] Ann Surg. 2007 Dec;246(6):966-74; discussion 974-5 [18043098.001]

[Cites] PLoS Med. 2006 Dec;3(12):e516 [17194196.001]

[Cites] Nat Genet. 1996 Oct;14(2):141-5 [8841182.001]

[Cites] J Hepatobiliary Pancreat Surg. 2004;11(6):434-7 [15619022.001]

[Cites] Mod Pathol. 2007 Feb;20 Suppl 1:S61-70 [17486053.001]

[Cites] Pancreatology. 2007;7(5-6):514-25 [17912015.001]

[Cites] Br J Cancer. 1985 Aug;52(2):271-3 [4027169.001]

[Cites] Gut. 2007 Aug;56(8):1134-52 [17625148.001]

[Cites] Cancer Res. 2004 Apr 1;64(7):2634-8 [15059921.001]

(PMID = 26192174.001).

[ISSN] 1865-7257

[Journal-full-title] Clinical journal of gastroenterology

[ISO-abbreviation] Clin J Gastroenterol

[Language] eng

[Publication-type] Journal Article

[Publication-country] Japan

[Keywords] NOTNLM ; Familial pancreatic cancer / Lobular parenchymal atrophy / PanIN / Pancreatoduodenectomy

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Computed tomography of pancreatic tumors].

Computed tomography (CT) and in particular multi-detector row computed tomography (MDCT), also known as multislice CT (MSCT), is ideally suited for detecting pancreatic tumors because of the high spatial resolution.The method of choice is hydro-CT which involves distension of the stomach and duodenum by administration of 1-1.5 l water as a negative contrast medium under medically induced hypotension by administration of buscopan.

The patient is laid on the right side at an angle of 30-45 degrees in order to obtain an artefact-free image of the close anatomical relationship around the pancreas head.

After the correct diagnosis of an adenocarcinoma has been made only 20% of all patients are shown to have a surgically resectable disease, but the overall survival rate is significantly higher after resection in combination with a multimodal tumor therapy strategy.

The reason is that the correct diagnosis of the resectability of the tumor is one of the main criteria for overall survival of these patients.

Currently practically all pancreatic tumors can be detected using MDCT and the detection rate varies between 70% and 100% (most recent literature references give a sensitivity of 89% and specificity up to 99%).

In some rare cases the differentiation between focal necrotizing pancreatitis and pancreatic carcinoma can be difficult even with sophisticated protocols.

MDCT is an ideal tool for the detection of neuroendocrine tumors, metastases and for the differentiation of cystic pancreatic lesions such as pseudocysts, microcystic adenomas or intraductal papillary mucinous neoplasms (IPMN).

Particularly, the differentiation of the latter into benign, borderline or malignant transformation is not always possible, but indirect signs, such as small nodules adjacent to the ductal wall, the diameter of the pancreatic duct, or a direct communication between cystic lesions and duct can be detected because of the high spatial resolution and is comparable to the findings in MRI.

[MeSH-major] Image Processing, Computer-Assisted. Imaging, Three-Dimensional. Pancreatic Neoplasms / diagnostic imaging. Tomography, Spiral Computed

[MeSH-minor] Adenocarcinoma / diagnostic imaging. Adenocarcinoma / mortality. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adenocarcinoma, Mucinous / diagnostic imaging. Adenocarcinoma, Mucinous / mortality. Adenocarcinoma, Mucinous / pathology. Adenocarcinoma, Mucinous / surgery. Carcinoma, Pancreatic Ductal / diagnostic imaging. Carcinoma, Pancreatic Ductal / mortality. Carcinoma, Pancreatic Ductal / pathology. Carcinoma, Pancreatic Ductal / surgery. Carcinoma, Papillary / diagnostic imaging. Carcinoma, Papillary / mortality. Carcinoma, Papillary / pathology. Carcinoma, Papillary / surgery. Diagnosis, Differential. Disease-Free Survival. Humans. Neuroendocrine Tumors / diagnostic imaging. Neuroendocrine Tumors / mortality. Neuroendocrine Tumors / pathology. Neuroendocrine Tumors / surgery. Pancreas / diagnostic imaging. Pancreas / pathology. Pancreatectomy. Pancreatic Pseudocyst / diagnostic imaging. Prognosis. Sensitivity and Specificity

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Br J Radiol. 2006 Nov;79(947):880-7 [16822803.001]

[Cites] AJR Am J Roentgenol. 2002 Sep;179(3):717-24 [12185052.001]

[Cites] Radiology. 2008 Sep;248(3):876-86 [18632526.001]

[Cites] Ann Surg. 2005 Sep;242(3):413-9; discussion 419-21 [16135927.001]

[Cites] Ann Surg. 1997 Oct;226(4):393-405; discussion 405-7 [9351708.001]

[Cites] J Gastrointest Surg. 2007 Mar;11(3):338-44 [17458608.001]

[Cites] Pancreatology. 2008;8(3):236-51 [18497542.001]

[Cites] Radiologe. 2003 Apr;43(4):293-300 [12721645.001]

[Cites] J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45 [16012297.001]

[Cites] Pancreas. 2005 Apr;30(3):218-22 [15782097.001]

[Cites] Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9 [15166958.001]

[Cites] N Engl J Med. 1992 Feb 13;326(7):455-65 [1732772.001]

[Cites] Am Surg. 2000 Apr;66(4):378-85; discussion 386 [10776876.001]

[Cites] Radiologe. 1998 Apr;38(4):279-86 [9622822.001]

[Cites] Radiographics. 2005 Nov-Dec;25(6):1471-84 [16284129.001]

[Cites] Eur Radiol. 2004 Jul;14 (7):1188-95 [15083335.001]

[Cites] Abdom Imaging. 2006 Sep-Oct;31(5):568-74 [16465578.001]

[Cites] J Clin Gastroenterol. 2008 Mar;42(3):284-94 [18223495.001]

[Cites] Eur Radiol. 2006 Aug;16(8):1709-18 [16550353.001]

[Cites] Pancreatology. 2006;6(1-2):17-32 [16327281.001]

[Cites] Digestion. 2003;68(1):24-33 [12949436.001]

[Cites] J Comput Assist Tomogr. 2005 Mar-Apr;29(2):170-5 [15772532.001]

[Cites] Radiology. 2000 Jul;216(1):163-71 [10887243.001]

[Cites] Eur Radiol. 2003 Jan;13(1):149-56 [12541123.001]

[Cites] Radiologe. 2008 Aug;48(8):752-63 [18633589.001]

[Cites] Eur J Surg Oncol. 2007 Aug;33(6):678-84 [17207960.001]

[Cites] AJR Am J Roentgenol. 1997 Aug;169(2):459-64 [9242754.001]

[Cites] Eur J Radiol. 2007 Jun;62(3):371-7 [17433598.001]

[Cites] Chirurg. 2003 Mar;74(3):202-7 [12647076.001]

[Cites] CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30 [16514137.001]

[Cites] Cancer. 2006 Jun 25;108(3):163-73 [16550572.001]

[Cites] Histopathology. 2008 Apr;52(5):539-51 [17903202.001]

[Cites] N Engl J Med. 2004 Sep 16;351(12):1218-26 [15371579.001]

[Cites] Radiologe. 1996 May;36(5):397-405 [8778924.001]

[Cites] J Magn Reson Imaging. 2007 Jul;26(1):86-93 [17659551.001]

[Cites] Dtsch Med Wochenschr. 2007 Apr 13;132(15):813-7 [17427092.001]

[Cites] Arch Surg. 1998 Jan;133(1):61-5 [9438761.001]

[Cites] Ann Surg Oncol. 2006 Jan;13(1):75-85 [16372157.001]

[Cites] Pancreatology. 2008;8(2):199-203 [18434757.001]

[Cites] Radiology. 2006 Mar;238(3):912-9 [16439566.001]

[Cites] World J Surg. 2006 Aug;30(8):1553-9 [16773248.001]

[Cites] AJR Am J Roentgenol. 2003 Feb;180(2):475-80 [12540455.001]

[Cites] Pancreas. 2006 Aug;33(2):111-8 [16868475.001]

[Cites] JOP. 2007 Mar 10;8(2):214-22 [17356246.001]

[Cites] Pancreatology. 2008;8(2):135-41 [18382099.001]

[Cites] AJR Am J Roentgenol. 2003 May;180(5):1311-23 [12704043.001]

[Cites] Pancreatology. 2008;8(2):204-10 [18434758.001]

[Cites] Radiologe. 2006 May;46(5):421-37; quiz 438 [16715226.001]

[Cites] Rofo. 1998 Mar;168(3):211-6 [9551105.001]

[Cites] Ann Surg. 2004 May;239(5):678-85; discussion 685-7 [15082972.001]

[Cites] AJR Am J Roentgenol. 1990 Nov;155(5):995-6 [2120971.001]

[Cites] Surg Clin North Am. 1995 Oct;75(5):1001-16 [7660245.001]

[Cites] Ann Surg. 2004 Mar;239(3):400-8 [15075659.001]

[Cites] J Gastrointest Surg. 1999 May-Jun;3(3):233-43 [10481116.001]

[Cites] Eur Radiol. 2007 Mar;17(3):638-49 [17021700.001]

[Cites] N Engl J Med. 2004 Mar 18;350(12):1200-10 [15028824.001]

[Cites] AJR Am J Roentgenol. 2006 Dec;187(6):1513-20 [17114545.001]

[Cites] Pancreatology. 2009;9(5):621-30 [19657217.001]

[Cites] Ann Surg. 2007 Oct;246(4):644-51; discussion 651-4 [17893501.001]

[Cites] Radiology. 1993 Mar;186(3):799-802 [8381551.001]

[Cites] Pancreatology. 2001;1(6):648-55 [12120249.001]

[Cites] J Gastrointest Surg. 1998 Sep-Oct;2(5):472-82 [9843608.001]

[Cites] J Gastrointest Surg. 2008 Jan;12(1):101-9 [17917784.001]

(PMID = 19137277.001).

[ISSN] 1432-2102

[Journal-full-title] Der Radiologe

[ISO-abbreviation] Radiologe

[Language] ger

[Publication-type] Journal Article; Review

[Publication-country] Germany

[Number-of-references] 71

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] An unusual case of pancreatic cancer with leptomeningeal infiltration.

INTRODUCTION: Pancreatic cancer is a common malignancy and often presents at an advanced stage.

We aim to describe an unusual case of leptomeningeal involvement from pancreatic cancer.

CT scan of the abdomen showed subtle narrowing of the common bile duct and pancreatic ducts.

Endoscopic ultrasound showed a 5-cm lesion in the head of the pancreas with adenocarcinoma cells on fine needle aspiration.

DISCUSSION: This case represents the unusual presentation of advanced leptomeningeal carcinomatosis in a locally early stage pancreatic adenocarcinoma.

[MeSH-major] Adenocarcinoma / secondary. Meningeal Carcinomatosis / secondary. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / pathology

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

Hazardous Substances Data Bank. CYTARABINE .

Hazardous Substances Data Bank. HYDROCORTISONE .

Hazardous Substances Data Bank. METHOTREXATE .

NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Neurology. 2006 Mar 14;66(5):783; author reply 783 [16534138.001]

[Cites] CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 [15761078.001]

[Cites] Ann Oncol. 2004;15 Suppl 4:iv285-91 [15477323.001]

[Cites] Neurochirurgia (Stuttg). 1980 Jan;23(1):13-7 [7352044.001]

[Cites] Cancer Treat Rev. 1999 Apr;25(2):103-19 [10395835.001]

[Cites] Gan To Kagaku Ryoho. 2008 Dec;35(13):2413-6 [19098414.001]

[Cites] Acta Neurol (Napoli). 1975 Jul-Aug;30(4):359-67 [1229842.001]

[Cites] Neurosurgery. 2000 Jul;47(1):49-54; discussion 54-5 [10917346.001]

[Cites] Cancer Treat Res. 2005;125:147-58 [16211888.001]

[Cites] Ann Oncol. 2008 Jul;19(7):1224-30 [18381371.001]

[Cites] Ann Oncol. 1996 Oct;7(8):773-86 [8922190.001]

(PMID = 20069465.001).

[ISSN] 1941-6636

[Journal-full-title] Journal of gastrointestinal cancer

[ISO-abbreviation] J Gastrointest Cancer

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] United States

[Chemical-registry-number] 0 / Anti-Inflammatory Agents; 0 / Antimetabolites, Antineoplastic; 04079A1RDZ / Cytarabine; WI4X0X7BPJ / Hydrocortisone; YL5FZ2Y5U1 / Methotrexate

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Pancreatic adenocarcinoma.

Adenocarcinoma is the most common malignant pancreatic tumor, affecting the head of the pancreas in 60-70% of cases.

By the time of diagnosis, at least 80% of tumors are unresectable.

Helical computed tomography (CT) is very effective in detecting and staging adenocarcinoma, with a sensitivity of up to 90% for detection and an accuracy of 80-90% for staging, but it has limitations in detecting small cancers.

MDCT has been found to be at least equivalent to contrast-enhanced magnetic resonance imaging (MRI) for detecting adenocarcinoma.

Mangafodipir-enhanced MRI reveals a very high tumor-pancreas contrast, which helps in diagnosing small cancers.

It is the technique of choice for image-guided biopsy if a histologic diagnosis is required for further therapy.

[MeSH-major] Adenocarcinoma / diagnosis. Pancreatic Neoplasms / diagnosis. Tomography, X-Ray Computed

MedlinePlus Health Information. consumer health - CT Scans.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Radiology. 2000 Mar;214(3):849-55 [10715057.001]

[Cites] Radiology. 2003 Oct;229(1):81-90 [14519871.001]

[Cites] Eur Radiol. 2004 Jan;14(1):14-20 [14730384.001]

[Cites] AJR Am J Roentgenol. 2002 Sep;179(3):717-24 [12185052.001]

[Cites] Gastrointest Endosc. 2002 Aug;56(2):218-24 [12145600.001]

[Cites] Abdom Imaging. 1997 Jul-Aug;22(4):429-33 [9157866.001]

[Cites] Ann Intern Med. 2004 Nov 16;141(10 ):753-63 [15545675.001]

[Cites] Ann Surg. 1997 Oct;226(4):393-405; discussion 405-7 [9351708.001]

[Cites] J Comput Assist Tomogr. 2005 Jul-Aug;29(4):438-45 [16012297.001]

[Cites] Abdom Imaging. 1997 Mar-Apr;22(2):204-7 [9013536.001]

[Cites] AJR Am J Roentgenol. 2005 Sep;185(3):700-3 [16120921.001]

[Cites] Am J Surg. 1991 Jan;161(1):120-4; discussion 124-5 [1987845.001]

[Cites] N Engl J Med. 1992 Feb 13;326(7):455-65 [1732772.001]

[Cites] Pancreatology. 2001;1(6):610-24 [12120244.001]

[Cites] AJR Am J Roentgenol. 1998 Mar;170(3):649-52 [9490946.001]

[Cites] Eur Radiol. 2005 Nov;15 Suppl 4:D96-9 [16479656.001]

[Cites] J Clin Gastroenterol. 2001 Mar;32(3):231-4 [11246351.001]

[Cites] Radiologe. 1998 Apr;38(4):279-86 [9622822.001]

[Cites] Radiology. 1997 Nov;205(2):513-8 [9356637.001]

[Cites] Eur Radiol. 2006 Aug;16(8):1709-18 [16550353.001]

[Cites] J Comput Assist Tomogr. 2005 Mar-Apr;29(2):170-5 [15772532.001]

[Cites] Br J Surg. 2004 Nov;91(11):1410-27 [15499648.001]

[Cites] J Gastrointest Surg. 2003 Jan;7(1):118-26; discussion 127-8 [12559193.001]

[Cites] Radiology. 1991 Aug;180(2):337-9 [1906189.001]

[Cites] N Engl J Med. 1993 May 20;328(20):1433-7 [8479461.001]

[Cites] AJR Am J Roentgenol. 2004 Mar;182(3):619-23 [14975959.001]

[Cites] Br J Radiol. 2000 Nov;73(875):1165-9 [11144793.001]

[Cites] Ann Surg. 1990 Apr;211(4):447-58 [2322039.001]

[Cites] Radiology. 1993 Mar;186(3):795-8 [8430190.001]

[Cites] Radiographics. 2005 Jul-Aug;25(4):949-65 [16009817.001]

[Cites] Radiology. 2001 Oct;221(1):107-16 [11568327.001]

[Cites] AJR Am J Roentgenol. 1999 Dec;173(6):1513-8 [10584794.001]

[Cites] AJR Am J Roentgenol. 1998 May;170(5):1315-22 [9574609.001]

[Cites] Eur Radiol. 2005 Jun;15(6):1256-62 [15627187.001]

[Cites] Radiology. 2002 Sep;224(3):764-8 [12202711.001]

[Cites] Radiology. 1996 Jun;199(3):697-701 [8637990.001]

[Cites] Invest Radiol. 1999 Sep;34(9):589-95 [10485075.001]

[Cites] Int J Cancer. 1994 Nov 15;59(4):494-504 [7960219.001]

[Cites] Br J Radiol. 1998 May;71(845):492-6 [9691893.001]

[Cites] Eur Radiol. 2003 Dec;13 Suppl 5:M42-9 [14989611.001]

[Cites] Radiology. 2002 Dec;225(3):759-65 [12461258.001]

[Cites] Radiology. 1998 Feb;206(2):373-8 [9457188.001]

[Cites] AJR Am J Roentgenol. 1997 Jul;169(1):119-23 [9207510.001]

[Cites] Radiology. 1991 Jan;178(1):95-9 [1984331.001]

[Cites] Eur Radiol. 1996;6(1):14-8 [8797944.001]

[Cites] AJR Am J Roentgenol. 2000 Mar;174(3):677-84 [10701608.001]

[Cites] Am J Gastroenterol. 2005 Dec;100(12 ):2658-61 [16393216.001]

[Cites] Eur Radiol. 2002 Dec;12(12):2998-3008 [12439582.001]

[Cites] Radiology. 2006 Nov;241(2):441-8 [16982815.001]

[Cites] AJR Am J Roentgenol. 2004 Feb;182(2):419-25 [14736675.001]

[Cites] Arch Surg. 1990 Feb;125(2):230-3 [2154172.001]

[Cites] Radiologe. 2006 May;46(5):421-37; quiz 438 [16715226.001]

[Cites] Radiology. 1997 Mar;202(3):655-62 [9051012.001]

[Cites] J Magn Reson Imaging. 2000 Aug;12 (2):261-8 [10931589.001]

[Cites] Radiology. 1995 May;195(2):327-32 [7724748.001]

[Cites] AJR Am J Roentgenol. 1997 Jun;168(6):1439-43 [9168704.001]

[Cites] Ann Surg. 2005 Aug;242(2):235-43 [16041214.001]

[Cites] Ann Surg. 2004 Nov;240(5):738-45 [15492552.001]

[Cites] J Natl Cancer Inst. 1997 Mar 19;89(6):442-6 [9091646.001]

[Cites] World J Surg. 1999 Sep;23(9):913-9 [10449820.001]

[Cites] Rofo. 2004 Nov;176(11):1624-33 [15497081.001]

[Cites] J Comput Assist Tomogr. 2002 Sep-Oct;26(5):743-9 [12439309.001]

[Cites] Radiology. 1995 Nov;197(2):381-5 [7480681.001]

[Cites] Radiology. 2001 Jul;220(1):97-102 [11425979.001]

[Cites] Cancer. 2003 Oct 25;99(5):285-92 [14579295.001]

(PMID = 17021700.001).

[ISSN] 0938-7994

[Journal-full-title] European radiology

[ISO-abbreviation] Eur Radiol

[Language] eng

[Publication-type] Journal Article; Review

[Publication-country] Germany

[Chemical-registry-number] 0 / Contrast Media

[Number-of-references] 65

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy.

AIM: To develop a method of gross examination of pancreaticoduodenectomy specimens with pancreatic ductal adenocarcinoma, allowing adequate assessment of the entire pancreatic surface as a surgical margin, which would not affect the lymph node yield.

(1) period 2006-2007, when the pancreatic surface (except for the transection margin and superior mesenteric artery margin) was not examined;.

(2) period January-September 2008, when the posterior pancreatic surface (posterior circumferential radial margin) was examined using an improved method based on sampling of 2.0-2.5 mm thick consecutive slices perpendicular to the duodenal axis; and (3) period October 2008 - June 2009, when the whole surface of the pancreatic head was sampled using the approach mentioned above.

CONCLUSIONS: The newly proposed approach allowed adequate assessment of the entire pancreatic head surface as a surgical margin and reduced the risk of under-detection of R1 status.

[MeSH-major] Carcinoma, Pancreatic Ductal / secondary. Lymph Nodes / pathology. Pancreatic Neoplasms / pathology. Pancreaticoduodenectomy

[MeSH-minor] Aged. Female. Humans. Lymphatic Metastasis / diagnosis. Male. Middle Aged. Neoplasm, Residual. Retrospective Studies

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 20085515.001).

[ISSN] 1465-3931

[Journal-full-title] Pathology

[ISO-abbreviation] Pathology

[Language] eng

[Publication-type] Comparative Study; Journal Article

[Publication-country] England

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Endoscopic diagnosis of squamous cell carcinoma of the pancreas invading the stomach.

CONTEXT: Squamous cell carcinoma of the pancreas is an unusual tumor due to the absence of squamous cells in the normal pancreas.

Its clinical presentation is similar to that of adenocarcinoma of the pancreas and is usually diagnosed intraoperatively or at autopsy.

Contrast-enhanced computerized tomography revealed a heterogeneous enhancing mass in the head of pancreas and upper gastrointestinal endoscopy revealed an ulcerated polypoidal lesion in the stomach; the endoscopic biopsies taken from this region revealed infiltration of the lamina propria with malignant squamous cells.

CONCLUSION: A rare case of squamous cell carcinoma of the head of the pancreas presenting with obstructive jaundice and gastric outlet obstruction and in which diagnosis was established by endoscopic biopsies of the stomach has been described.

[MeSH-major] Carcinoma, Squamous Cell / diagnosis. Pancreatic Neoplasms / diagnosis. Stomach / pathology

[MeSH-minor] Diagnosis, Differential. Endoscopy, Gastrointestinal. Humans. Male. Middle Aged

Genetic Alliance. consumer health - Carcinoma, Squamous Cell.

Genetic Alliance. consumer health - Stomach carcinoma.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19287113.001).

[ISSN] 1590-8577

[Journal-full-title] JOP : Journal of the pancreas

[ISO-abbreviation] JOP

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Italy

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Primary pancreatic lymphoma. Report of five cases.

Primary pancreatic lymphoma (PPL) is a very rare disease.

None of these patients had evidence of extrapancreatic disease and they were categorized as PPL involving pancreas only (stage IE, 3 patients) or pancreas and peripancreatic lymph nodes (stage IIE, 2 patients).

Imaging techniques showed a mass of the pancreatic head in all cases.

The histological diagnosis (3 diffuse-large cell non-Hodgkin's lymphoma and 2 lymphoplasmacytic lymphoma/immunocytoma) was made by ultrasound-guided fine needle aspiration biopsy and tissue core fine-needle biopsy in three patients and by surgery in the remaining two patients.

1) imaging techniques can suggest the suspicion of PPL but are unable to distinguish PPL from pancreatic adenocarcinoma;.

2) histological diagnosis can be easily obtained by percutaneous US-guided tissue core biopsy;.

3) surgery can be avoided both for diagnosis and therapy but the treatment of choice of PPL may only be evaluated on a larger series of patients.

[MeSH-major] Lymphoma, Non-Hodgkin / diagnosis. Lymphoma, Non-Hodgkin / therapy. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / therapy

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15713583.001).

[ISSN] 1592-8721

[Journal-full-title] Haematologica

[ISO-abbreviation] Haematologica

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] Italy

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.

BACKGROUND: Nowadays, there is a remarkable rise in resectability rate of periampullary adenocarcinoma and the mortality and morbidity of the pancreaticoduodenectomy procedure have been reduced remarkably, while the 5 year survival rates of patients with carcinoma of the head of the pancreas are still below 25%.

We conducted this retrospective study to evaluate the clinical outcome of radical pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy as a surgical therapy for adenocarcinoma of the head of the pancreas.

METHODS: Twenty cases with adenocarcinoma of the head of the pancreas were treated by standard pancreaticoduodenectomy (removing only the peripancreatic lymph nodes en bloc with the tumour) from 1994 to 1997, and 46 cases with the same disease underwent extended retroperitoneal lymphadenectomy associated with standard pancreaticoduodenectomy from 1998 to 2002.

Of the 46 cases in the radical group, 26% (12/46) had metastatic adenocarcinoma in the resected retroperitoneal lymph nodes.

[MeSH-major] Adenocarcinoma / surgery. Lymph Node Excision. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16313840.001).

[ISSN] 0366-6999

[Journal-full-title] Chinese medical journal

[ISO-abbreviation] Chin. Med. J.

[Language] eng

[Publication-type] Journal Article

[Publication-country] China

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases].

[Transliterated title] Tratamiento quirúrgico del adenocarcinoma pancreático mediante duodenopancreatectomía cefálica (parte 2). Seguimiento a largo plazo tras 204 casos.

INTRODUCTION: Surgery is the accepted treatment in adenocarcinoma of the head of the pancreas; however, the long-term survival continues to be low.

The aim of this study is to define prognostic factors of long-term survival after cephalic duodenopancreatectomy due to pancreatic adenocarcinoma.

MATERIAL AND METHODS: We have collected data on the treatment of adenocarcinoma of the head of the pancreas (ADHP) by means of a cephalic duodenopancreatectomy (CDP) performed n the Bellvitge University Hospital (Barcelona) from 1991 to 2007.

CONCLUSIONS: Surgery of head of the pancreas adenocarcinoma must include an adequate lymphadectomy, and must be performed with a low morbidity and without the need of a peri-operative transfusion.

[MeSH-major] Adenocarcinoma / surgery. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Copyright] Copyright © 2010 AEC. Published by Elsevier Espana. All rights reserved.

[CommentIn] Cir Esp. 2011 Jun-Jul;89(6):411; author reply 412 [21550599.001]

(PMID = 21030012.001).

[ISSN] 1578-147X

[Journal-full-title] Cirugía española

[ISO-abbreviation] Cir Esp

[Language] spa

[Publication-type] English Abstract; Journal Article

[Publication-country] Spain

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of pancreatic head adenocarcinoma?

BACKGROUND: We hypothesized that the high-quality images from multidetector-row computed tomography (MDCT) would lead to improved sensitivity and specificity for predicting resectable pancreatic head adenocarcinoma, thus diminishing the value of staging laparoscopy.

CONCLUSIONS: Despite the improvements in image quality obtained with multidetector-row technology, CT imaging remains a relatively nonspecific test for predicting resectability in patients with adenocarcinoma of the head of the pancreas.

Minimally invasive modalities with higher specificity, particularly laparoscopy, continue to have an important role in staging pancreatic head adenocarcinoma.

[MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / surgery. Laparoscopy. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / surgery. Tomography, X-Ray Computed

MedlinePlus Health Information. consumer health - CT Scans.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Br J Surg. 2001 Mar;88(3):325-37 [11260096.001]

[Cites] Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3 [7794076.001]

[Cites] Am J Surg. 1999 May;177(5):428-32 [10365885.001]

[Cites] J Gastrointest Surg. 2000 May-Jun;4(3):233-7; discussion 238-9 [10769085.001]

[Cites] Radiology. 2001 Oct;221(1):93-106 [11568326.001]

[Cites] Ann Surg. 1993 Feb;217(2):144-8 [8094952.001]

[Cites] AJR Am J Roentgenol. 1999 Dec;173(6):1513-8 [10584794.001]

[Cites] Am J Surg. 1994 Jan;167(1):104-11; discussion 111-3 [7906097.001]

[Cites] J Am Coll Surg. 1998 Jun;186(6):675-82 [9632157.001]

[Cites] Radiology. 2002 Dec;225(3):759-65 [12461258.001]

[Cites] Radiology. 1998 Feb;206(2):373-8 [9457188.001]

[Cites] J Clin Oncol. 1997 Mar;15(3):928-37 [9060530.001]

[Cites] Ann Surg. 2002 Jan;235(1):1-7 [11753036.001]

[Cites] AJR Am J Roentgenol. 1997 Jun;168(6):1439-43 [9168704.001]

[Cites] J Gastrointest Surg. 2001 Nov-Dec;5(6):626-33 [12086901.001]

(PMID = 15624058.001).

[ISSN] 1432-2218

[Journal-full-title] Surgical endoscopy

[ISO-abbreviation] Surg Endosc

[Language] eng

[Publication-type] Journal Article

[Publication-country] Germany

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] [Local recurrence of pancreatic cancer successfully treated with gemcitabine].

We report a patient for whom systemic chemotherapy using gemcitabine was effective against local recurrence of pancreatic cancer.

A 58-year-old man underwent pancreatoduodenectomy for a pancreatic head cancer.

The diagnosis was Stage IVb poorly-differentiated tubular adenocarcinoma, scirrhous type, pT4, PL (+), P0, H0, pN2.

Gastroscopy and CT examination revealed a mass at the cut-end of the pancreas invading the stomach.

The recurrent tumor in the stomach disappeared, and the mass at the cut-end of the pancreas became small.

Two years after the diagnosis of recurrence, he returned to work, and his chemotherapy is being continued as an outpatient.

[MeSH-major] Adenocarcinoma / drug therapy. Antimetabolites, Antineoplastic / therapeutic use. Deoxycytidine / analogs & derivatives. Deoxycytidine / therapeutic use. Neoplasm Recurrence, Local / drug therapy. Pancreatic Neoplasms / drug therapy. Stomach Neoplasms / drug therapy

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

MedlinePlus Health Information. consumer health - Stomach Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 15751641.001).

[ISSN] 0385-0684

[Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy

[ISO-abbreviation] Gan To Kagaku Ryoho

[Language] jpn

[Publication-type] Case Reports; English Abstract; Journal Article

[Publication-country] Japan

[Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Pancreatic tail cancer with sole manifestation of left flank pain: a very rare presentation.

Pancreatic cancer is sometimes called a "silent disease" because it often causes no symptoms in the early stage.

The symptoms can be quite vague and various depending on the location of cancer in the pancreas.

The anatomic site distribution is 78% in the head of the pancreas, 11% in the body, and 11% in the tail.

Pancreatic cancer is rarely detected in the early stage, and it is very uncommon to diagnose pancreatic tail cancer during an emergency department visit.

The manifestation of pancreatic tail cancer as left flank pain is very rare and has seldom been identified in the literature.

We present a case of pancreatic tail cancer with the sole manifestation of dull left flank pain.

Radiographic evaluation with computed tomography was performed, and pancreatic tail tumor with multiple metastases was found unexpectedly.

We review the literature and discuss this rare presentation of pancreatic tail cancer.

[MeSH-major] Flank Pain / diagnosis. Pancreatic Neoplasms / diagnosis

[MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / pathology. Fatal Outcome. Female. Humans. Liver Neoplasms / pathology. Liver Neoplasms / secondary. Medical Oncology / methods. Middle Aged. Neoplasm Metastasis. Prognosis. Tomography, X-Ray Computed

Genetic Alliance. consumer health - Pancreatic cancer.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 18635419.001).

[ISSN] 1607-551X

[Journal-full-title] The Kaohsiung journal of medical sciences

[ISO-abbreviation] Kaohsiung J. Med. Sci.

[Language] eng

[Publication-type] Case Reports; Journal Article

[Publication-country] China (Republic : 1949- )

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Primary pancreatic lymphomas.

Primary pancreatic lymphomas are extremely rare.

Clinically, primary pancreatic lymphomas usually present with symptoms of carcinoma of the pancreatic head.

Patients with primary pancreatic lymphomas are between 35 and 75 years of age and with a strong male predominance.

An accurate cytopathologic diagnosis by fine-needle aspiration (FNA) is imperative because the primary treatment is non-surgical.

FNA coupled with flow cytometry analysis appears to be highly accurate in the diagnosis of primary pancreatic lymphomas.

Fluorescence in-situ hybridisation technique has been established its role in the diagnosis of lymphoid malignancies, including primary pancreatic lymphomas.

The differential diagnoses of primary pancreatic lymphomas include secondary lymphoma, pancreatic endocrine neoplasm, and florid chronic pancreatitis.

Primary pancreatic lymphomas has a much better prognosis than adenocarcinoma of the pancreas.

[MeSH-major] Lymphoma / diagnosis. Pancreatic Neoplasms / diagnosis

MedlinePlus Health Information. consumer health - Lymphoma.

MedlinePlus Health Information. consumer health - Pancreatic Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 16685107.001).

[ISSN] 1590-8577

[Journal-full-title] JOP : Journal of the pancreas

[ISO-abbreviation] JOP

[Language] eng

[Publication-type] Journal Article; Review

[Publication-country] Italy

[Number-of-references] 40

   

[Fulltext service] Download fulltext PDF of this article and others, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

[Title] Castleman's disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome.

BACKGROUND: Castleman's disease of the pancreas is a very rare condition that may resemble more common disease entities as well as pancreatic cancer.

CASE PRESENTATION: Here we report the case of a 58-year-old African American male with an incidentally discovered lesion in the head of the pancreas.

CONCLUSION: To date, eight cases of Castleman's disease associated with the pancreas have been described in the world literature.

We report the first case of unicentric disease situated within the head of the pancreas.

In addition, we discuss the diagnostic dilemma Castleman's disease may present to the pancreatic surgeon and review current data on pathogenesis, treatment, and outcome.

[MeSH-major] Giant Lymph Node Hyperplasia / pathology. Pancreatic Diseases / pathology

[MeSH-minor] Adenocarcinoma / pathology. Diagnosis, Differential. Humans. Male. Middle Aged. Pancreatic Neoplasms / pathology. Pancreaticoduodenectomy. Tomography, X-Ray Computed

Genetic Alliance. consumer health - Castleman's Disease.

MedlinePlus Health Information. consumer health - Pancreatic Diseases.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] N Engl J Med. 1994 Mar 3;330(9):602-5 [8302342.001]

[Cites] J Comput Assist Tomogr. 1982 Dec;6(6):1193-5 [7174940.001]

[Cites] Cancer. 1979 Aug;44(2):457-62 [476562.001]

[Cites] Radiology. 1979 Feb;130(2):311-5 [760140.001]

[Cites] Int J Radiat Oncol Biol Phys. 1978 Nov-Dec;4(11-12):1045-8 [102620.001]

[Cites] AJR Am J Roentgenol. 1978 Mar;130(3):447-50 [415545.001]

[Cites] Am J Clin Pathol. 1978 Jan;69(1):86-90 [619617.001]

[Cites] Cancer. 1972 Mar;29(3):670-83 [4551306.001]

[Cites] Can Med Assoc J. 1968 Dec 28;99(25):1259-62 [5700853.001]

[Cites] Cancer. 1967 Apr;20(4):525-36 [6019827.001]

[Cites] J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):180-3 [10779037.001]

[Cites] Aust N Z J Surg. 1994 Mar;64(3):219-21 [8117206.001]

[Cites] World J Gastroenterol. 2005 Nov 14;11(42):6725-7 [16425374.001]

[Cites] Cancer. 1956 Jul-Aug;9(4):822-30 [13356266.001]

[Cites] JOP. 2004 Nov;5(6):491-4 [15536288.001]

[Cites] APMIS. 2005 Apr;113(4):288-95 [15865611.001]

[Cites] Pancreas. 1994 Sep;9(5):668-70 [7809024.001]

[Cites] Cancer Treat Rev. 1995 Jul;21(4):291-310 [7585657.001]

[Cites] AIDS. 1996 Jan;10(1):61-7 [8924253.001]

[Cites] Ann Hematol. 1996 Jul;73(1):47-50 [8695726.001]

[Cites] J Hepatol. 1997 Jan;26(1):209-14 [9148014.001]

[Cites] Cancer. 1999 Feb 1;85(3):706-17 [10091744.001]

[Cites] Gastroenterol Clin Biol. 1999 Apr;23(4):536-8 [10416122.001]

[Cites] Acta Chir Belg. 1993 Sep-Oct;93(5):227-9 [8266757.001]

[Cites] Cancer Invest. 1993;11(6):732-42 [8221206.001]

[Cites] Hum Pathol. 1993 Aug;24(8):833-9 [8375854.001]

[Cites] Comput Med Imaging Graph. 1993 Mar-Apr;17(2):107-17 [8518992.001]

[Cites] Am J Clin Pathol. 1992 Dec;98(6):633-6 [1462961.001]

[Cites] Presse Med. 1992 Jan 18;21(2):86 [1531532.001]

[Cites] Blood. 1991 Dec 1;78(11):2923-30 [1954381.001]

[Cites] Cancer. 1991 Sep 15;68(6):1365-72 [1873789.001]

[Cites] Hum Pathol. 1991 Jul;22(7):724-6 [2071115.001]

[Cites] Br J Radiol. 1990 Aug;63(752):648-50 [2400884.001]

[Cites] J Clin Invest. 1990 Aug;86(2):592-9 [2384605.001]

[Cites] Am J Surg Pathol. 1990 Jul;14(7):603-14 [2356921.001]

[Cites] Semin Diagn Pathol. 1988 Nov;5(4):346-64 [2464187.001]

[Cites] Blood. 1989 Sep;74(4):1360-7 [2788466.001]

[Cites] Surgery. 1989 Nov;106(5):884-7 [2683174.001]

[Cites] Cancer. 1983 Mar 1;51(5):808-10 [6821846.001]

[Cites] Am J Clin Pathol. 1985 Jan;83(1):27-33 [3871303.001]

[Cites] Hum Pathol. 1985 Feb;16(2):162-72 [2579015.001]

[Cites] Hum Pathol. 1985 Mar;16(3):202-5 [3871724.001]

[Cites] J Comput Assist Tomogr. 1985 May-Jun;9(3):570-2 [3886726.001]

[Cites] Cancer. 1985 Aug 15;56(4):876-9 [4016679.001]

[Cites] J Clin Oncol. 1985 Sep;3(9):1202-16 [4031967.001]

[Cites] Cancer. 1987 Nov 15;60(10):2454-8 [3478119.001]

(PMID = 18028547.001).

[ISSN] 1477-7819

[Journal-full-title] World journal of surgical oncology

[ISO-abbreviation] World J Surg Oncol

[Language] eng

[Publication-type] Case Reports; Journal Article; Review

[Publication-country] England

[Number-of-references] 47

[Other-IDs] NLM/ PMC2206042

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

Most commonly reported malignancies include cholangiocarcinoma, adenocarcinoma, and gallbladder cancer.

Endoscopic retrograde cholangiopancreatography and direct cholangioscopy revealed a mass at the biliary bifurcation, a 4-cm choledochal cyst with multiple calculi, absence of anomalous pancreaticobiliary ductal union, and multiple calcifications in the pancreatic head.

We report the associated rare finding of chronic calcific pancreatitis, without anomaly of the pancreatic biliary junction.

[MeSH-minor] Adult. Biopsy. Cholangiopancreatography, Endoscopic Retrograde. Female. Humans. Pancreatitis, Chronic / diagnosis. Pancreatitis, Chronic / etiology

Genetic Alliance. consumer health - Carcinoma, Squamous Cell.

MedlinePlus Health Information. consumer health - Bile Duct Cancer.

[Email] Email this result item

Email the results to the following email address:   [X] Close

[Cites] Nihon Geka Gakkai Zasshi. 1989 Jul;90(7):1026-31 [2796970.001]

[Cites] J Hepatobiliary Pancreat Surg. 2001;8(1):92-4 [11294296.001]

[Cites] Am J Surg. 2004 Jun;187(6):790-5 [15191877.001]

[Cites] HPB Surg. 1991 Sep;4(3):245-9; discussion 250 [1681890.001]

[Cites] Ann Surg. 1994 Nov;220(5):644-52 [7979612.001]

[Cites] J Hepatobiliary Pancreat Surg. 2003;10 (5):340-4 [14598133.001]

[Cites] Eur J Pediatr Surg. 2001 Feb;11(1):24-7 [11370978.001]

[Cites] Hepatogastroenterology. 2004 Jul-Aug;51(58):1187-90 [15239275.001]

[Cites] Arch Surg. 2004 Aug;139(8):855-60; discussion 860-2 [15302695.001]

[Cites] Arch Surg. 1988 Aug;123(8):984-6 [3395242.001]

[Cites] Arch Surg. 1983 Aug;118(8):986-8 [6870530.001]

[Cites] Am J Surg. 1977 Aug;134(2):263-9 [889044.001]

[Cites] Intern Med J. 2002 Sep-Oct;32(9-10):491 [12380705.001]

[Cites] Hepatogastroenterology. 2002 Jan-Feb;49(43):100-3 [11941929.001]

[Cites] Hepatogastroenterology. 2004 Sep-Oct;51(59):1504-5 [15362787.001]

[Cites] Eur J Pediatr Surg. 1995 Oct;5(5):265-70 [8555126.001]

[Cites] Pancreas. 1994 Sep;9(5):633-7 [7809018.001]

[Cites] Pediatr Surg Int. 2005 Nov;21(11):936-8 [16195912.001]

(PMID = 18274902.001).

[ISSN] 0163-2116

[Journal-full-title] Digestive diseases and sciences

[ISO-abbreviation] Dig. Dis. Sci.

[Language] eng

[Publication-type] Case Reports; Journal Article; Review

[Publication-country] United States

[Number-of-references] 19

   

[Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

[Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.

A 57 years old male patient is presented with a mucinous carcinoma of the caecum and an adenocarcinoma of the pancreas head.

His family history was significant for two cases of colon carcinoma, two cases of stomach cancer and a case of metacron endometrial and skin tumor as well.

[MeSH-minor] Adenocarcinoma, Mucinous / genetics. Adenocarcinoma, Mucinous / pathology. Cecal Neoplasms / genetics. Cecal Neoplasms / pathology. Family Health. Humans. Male. Middle Aged. Pancreatic Neoplasms / genetics. Pancreatic Neoplasms / pathology. Pedigree

Genetic Alliance. consumer health - Keratoacanthoma.

[Email] Email this result item

Email the results to the following email address:   [X] Close

(PMID = 19423266.001).

[ISSN] 1532-2157

[Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

[ISO-abbreviation] Eur J Surg Oncol

[Language] eng

[Publication-type] Case Reports; Journal Article; Review

[Publication-country] England

[Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / MLH1 protein, human; 0 / MLH2 protein, human; 0 / Neoplasm Proteins; 0 / Nuclear Proteins

[Number-of-references] 15